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ABSTRACT 
The recent growing interest and development of microfluidic paper-based analytical 
devices (µPADs) for point-of-care (POC) testing in human health in low-resource 
settings has great potential for the exploitation of these technologies in animal disease 
diagnosis. Sheep scab is a highly infectious, widespread and notifiable disease of sheep, 
which poses major economic and welfare concerns for the UK farming industry. The 
possibility of diagnosing sheep scab at the POC is, consequently, very important to 
controlling this disease. The overall aim of this project was, therefore, to develop 
µPADs based on a novel method of fabrication, in order to translate the existing lab-
based sheep scab ELISA (Pso o 2) and a biomarker test for haptoglobin (Hp) into paper-
based ELISA (P-ELISA), to enable POC diagnosis of this animal disease. In Chapter 3, 
the novel fabrication method is described, in Chapters 4 and 5, the translation of the lab-
based ELISAs (Hp and Pso o 2 respectively) are explained and in Chapter 6 the 
development of a µPAD for incorporation of the POC tests into a multiplexed, rapid 
assay is covered. Experiments showed that both ELISAs were successfully transferred 
onto paper and that the devices developed were suitable for POC testing. This study has 
resulted in a novel fabrication method for µPADs, in successfully translated existing 
ELISAs to P-ELISA and in novel solutions for the POC diagnosis of an important 
veterinary disease.  
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Chapter 1 – Introduction 
1.1 Introduction to the research 
Sheep scab is the most important ectoparasitic disease of sheep in the UK and it 
represents a significant threat to both animal welfare and farm economics, making a 
rapid and accurate diagnosis of paramount importance. Recent improvements in the 
diagnosis of the disease have considerably broadened the tools available to combat 
sheep scab. At the same time, there has been a growing need for low-cost, rapid and 
reliable diagnostic tests in veterinary medicine. A considerable number of point-of-care 
tests are presently available, allowing cost-effective and decentralised diagnosis. 
Although, extremely useful, these tests come with some limitations. Recent advances in 
the field of microfluidics have brought about new and exciting opportunities for human 
health diagnostics, and there is now great potential for these new technologies to be 
applied in the field of veterinary diagnostics.  
1.2 Sheep scab1 
1.2.1 Sheep scab, the disease and its presence in the UK 
Sheep scab is an allergic dermatitis caused by the non-burrowing ectoparasitic mite 
Psoroptes ovis. The disease is transmitted mainly by direct contact and is host specific, 
with the parasite spending its entire life-cycle on the sheep [1]. Mites, however, can 
survive off the sheep and remain infective for up to 16 days [2], making fences and 
handling facilities a possible alternative source of infestation, especially considering 
that a single ovigerous female is capable of producing an infestation [1]. The faecal 
deposition of P. ovis derived antigens/allergens on the skin of the host causes an intense 
inflammatory reaction, with marked pruritus resulting in self-trauma, extensive 
pyodermatitis, severe alopecia and considerable weight loss [3]. The sub-clinical phase 
can persist for 2 to 8 months in naturally occurring disease [4]. As lesions develop, they 
are distributed primarily along the trunk and if left untreated can quickly spread over the 
                                                 
1 Much of this section is adapted from a recently published article: Busin V., Burgess S., and Sargison N. 
(2015). Sheep scab, future perspective for disease diagnosis and control. Livestock 20(3): 156-159. 
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entire body (Figure 1). As clinical signs resolve the mite population can die out 
completely, while in other cases mites can survive in cryptic sites, such as the ear canal, 
the inguinal and the infraorbital fossae [4]. In these cases, while animals may not 
exhibit clinical signs, none the less they still represent a potential source of infestation. 
 
Figure 1 – An advanced case of sheep scab. It is evident that the lesion has spread across the entire 
body of the animal. (Valentina Busin). 
Sheep scab represents a significant threat to animal welfare and has a tremendous 
impact on sheep farming economics, with an estimated annual cost of £8 million to the 
UK sheep industry [5]. In a recent training program organized by the Agriculture & 
Horticulture Development Board (AHDB Beef & Lamb), called “Stamp out Scab”, the 
costs associated with an outbreak of scab reached £10.000, when diagnosis was delayed 
and treatment performed incorrectly [6]. Recent updates in legislation have made sheep 
scab a notifiable disease in Scotland. Based on the “Sheep Scab (Scotland) Order 2010” 
notification of sheep scab or suspected sheep scab to the Veterinary Authorities is 
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compulsory, with animal movement restrictions, notification to neighbouring farms, 
clearing of common lands and compulsory veterinary diagnosis to establish if the 
disease is present2. For England and Wales, under the “Sheep Scab Order 1997”, it is a 
criminal offence to move infested animals (except to enable treatment or immediate 
slaughter) or fail to treat sheep visibly affected by scab3. 
Despite active legislation, however, sheep scab is currently endemic in the UK [7], with 
prevalence ranging from 8.6% to as high as 36% [8] and a total of 657 notifications to 
the Animal and Plant Health Agency (APHA) in Scotland between 2010 and 20164. In 
particular, recent research has shown that 85% of flocks reporting a scab outbreak had a 
scab episode at least once in the past and 30% of these flocks had scab almost every 
year [9], with about 9% of UK farmers experiencing at least one outbreak of sheep scab 
a year [10]. These results highlight the reality that affected flocks are failing to 
eliminate the disease properly. Further research into the risk factors associated with 
disease outbreaks, has also shown that the risk of introducing sheep scab into a flock 
was increased up to 10-fold when confirmed cases of the disease where diagnosed in a 
neighbouring flock or in cases where common grazing was used [11]. 
Based on the severity of the disease and on the data shown by these recent studies, it is 
apparent that rapid and accurate diagnosis of sheep scab is of paramount importance, 
enabling the identification of cases prior to the advent of clinical signs (where possible) 
and therefore preventing further spread of disease and alleviating welfare concerns. 
1.2.2 Diagnosis of sheep scab 
The conventional diagnosis of P. ovis infestation is based on clinical observations and 
microscopic detection of mites in skin scrapings. Skin scrapings can be taken using a 
scalpel blade drawn at a right angle across the skin surface at the periphery of active 
lesions and observed microscopically under low magnification (x100) [12]. Although 
                                                 
2 http://www.legislation.gov.uk/ssi/2010/419/pdfs/ssi_20100419_en.pdf 
3 http://www.legislation.gov.uk/uksi/1997/968/contents/made 
4 www.gov.scot/Topics/farmingrural/Agriculture/amimal-welfare/Diseases/disease/notifications 
Chapter 1– Introduction 
4 
representing the conventional method for the diagnosis of ectoparasite infestation, it has 
been shown that this approach is often unable to detect sub-clinical infestation or sub-
clinical carrier hosts [13], with sensitivity as low as 18% in animals not showing 
classical clinical signs of pruritus and alopecia [14]. Consequently, by the time P. ovis 
mites are detected, they have often already spread to the rest of the flock. 
In the past few years, much work has been carried out to improve our knowledge of the 
causative agent [15] and of the host immune response to mite infestation [16]. 
Demonstration of specific antibodies against P. ovis in infested animals has allowed for 
several assays to be developed for antibody detection in sheep [14, 17, 18]. Some of the 
most promising antigens produced during sheep scab infestation are those homologous 
to house dust mite allergens, where a pronounced antibody response was detected [19, 
20]. One has attracted particular attention, Pso o 2, a small (16kDa) polypeptide 
(protein) of the mite group II allergen (Der f 2 and Lep d 2) [20]. In this case, the use of 
immunodiagnostic tests such as the enzyme-linked immunosorbent assay (ELISA), 
could represent a valid alternative to the skin-scraping method, with far higher 
sensitivity being obtained [21]. Recently, the Moredun Research Institute (MRI) has 
developed a diagnostic ELISA for the detection of host antibodies specific to the mite 
allergen Pso o 2, which has proven highly effective in the diagnosis of sub-clinical 
infestation, since an antibody response can be detected as early as 2 weeks post-
infestation [22]. A recombinant form of the mite protein Pso o 2 was synthesized [20] 
and used as a capture antigen in an indirect antibody ELISA for the detection of 
antigen-specific serum IgG. Testing performed on sheep serum samples of different 
origins and infestation status has demonstrated sensitivity of 93% and specificity of 
90% [22]. This assay has recently been further optimized and now achieves sensitivity 
of 98.2% and specificity of 96.5% (S. Burgess, Personal Communication). The same 
diagnostic assay was also used in the face of a natural outbreak, showing its efficacy in 
the detection of sub-clinical disease in the field [23]. 
The main disadvantage of this assay, however, is that host antibodies may be present in 
previously-infested but successfully-treated animals for a prolonged period after 
treatment (3-6 months) potentially leading to false positives [24]. This is due to the 
considerable long half-life of Pso o 2 antibodies (56 days) following successful 
Chapter 1– Introduction 
5 
treatment. Serum biomarkers (BMs) are generally host inflammatory proteins, which 
represent either specific, or non-specific indicators of disease, and/or current disease 
status. When combined with more specific immunodiagnostic elements (i.e. specific 
antibody tests), BMs have been shown to have the potential to discriminate between 
active infestation and disease resolution or successful treatment. A specific group of 
BMs are the acute phase proteins (APPs) which are serum proteins that increase rapidly 
following external or internal challenges, providing a quantification of the tissue 
damage in a diseased animal [25]. Two APPs have attracted attention in the veterinary 
field: haptoglobin (Hp) and serum amyloid A (SAA) [26-29]. Hp is an alpha-globulin 
constituent which is involved in reducing oxidative damage by binding free 
haemoglobin [25], usually present in two subunits, an α chain of 22kDa and a ß chain of 
37kDa [29]. Increases in circulating Hp levels are caused by tissue damage, 
infection/infestation or inflammation and can be used to measure the course of infection 
as well as the response to therapy, while sex, age, pregnancy and lactation do not seem 
to influence circulating levels of Hp [30]. SAA is an apolipoprotein, the physiological 
role of which is still not fully understood [25], with a molecular weight of ~13kDa. 
Their application as diagnostic tools for sheep scab has also been recently investigated, 
showing a statistically significant increase in their serum levels with disease 
progression, but more importantly a rapid decline (half-life of less than 3 days) 
following successful treatment [31]. Specifically, serum Hp levels increased from a 
mean of 0.3mg/ml up to 3.53mg/ml at week 5 of infestation and down to 1.57mg/ml one 
week post-treatment and to pre-infestation levels between day 10 and 14 days post-
treatment (half-life of Hp in serum post-treatment was 2.3 days). SAA is present at 
much lower quantities in the circulation (0.82µg/ml) prior to infestation, but peaked at 
284.75µg/ml 5 weeks post-infestation. Following treatment, levels reached pre-
infestation levels within 10 days (half-life for SAA was of 0.84 days) [31]. Currently, 
there are commercially available lab-based tests in the form of a colorimetric assay for 
HP analysis (Tridelta Development Ltd, Ireland) and as ELISA for SAA (Life 
Diagnostics Inc., UK). The first one is an indirect method of Hp measurement, based on 
the binding of Hp to haemoglobin. It is relatively quick but can be unreliable if the 
samples are haemolysed. The lab-based ELISA used for SAA measurement, is 
expensive and validated only for use in cow and goat serum. A diagnostic test 
combining the existing Pso o 2 antibody ELISA with an antigen ELISA for detection of 
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specific APPs, could represent a very powerful, improved diagnostic tool for sheep 
scab. Serum antibodies against Pso o 2 would inform on the contact between the host 
and the parasite, while the level of APPs would inform on the status of the disease (e.g. 
active vs resolved infestation). 
1.3 Point-of-care diagnostics5 
Point-of-care (POC) diagnostics is an area that has attracted considerable attention in 
the last decade. Testing at POC means that analytical procedures are carried out at the 
side of or near to the patient [32], for this reason, it is also sometimes referred to as 
“bed-side” testing [33]. The reasons for the considerable interest in the field of POC 
diagnostics are numerous: the potential to decrease costs of diagnosis [34], increasing 
the accessibility of these types of test to disadvantaged populations [35], and reducing 
the time between sampling and a treatment decision [36]. 
Following the global trend towards more affordable and accessible diagnostic testing, 
the Sexually Transmitted Diseases Diagnostics Initiative (SDI) within the World Health 
Organization (WHO) recently established a set of benchmark criteria for the ideal rapid 
test, under the acronym “ASSURED” [37]:  Affordable, Sensitive, Specific, User-
friendly (simple to perform in a few steps, with minimal technical training), Robust and 
Rapid (results available in less than 30 minutes), Equipment-free, Deliverable to those 
who need them. Ideally, POC tests should respect all or as many as possible of these 
characteristics [38]. 
1.3.1 Point-of-care testing in veterinary medicine 
In the field of veterinary diagnostics, there is a similar need for low-cost, reliable and 
rapid diagnostic tests to be carried out at the POC [39]. So called on-site or animal-side 
tests will have considerable advantages over lab-based testing, which usually involves 
                                                 
5 Much of this section is adapted from a recently published review article: Busin V., Wells B., Kesaudy-
Kerhoas M., Shu W., and Burgess S. (2016). Opportunities and challenges for the application of 
microfluidic technologies in point-of-care veterinary diagnostics. Molecular and cellular probes, 30(5): 
331-341. 
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laborious and expensive laboratory techniques and dedicated technical personnel. All of 
the analytical processes involved in testing, from collection of the sample to 
communication of the results, could potentially be performed in a single step, 
considerably reducing the time between testing and treatment [40]. This can translate 
into more affordable veterinary care, reduced handling of animals, targeted treatments 
and rapid testing in more remote geographic areas.  
The need for more affordable, rapid and accessible tests is a recurrent theme in the 
literature, in particular as an invaluable tool in dealing with diseases that either represent 
a threat to public health [41], have substantial impact on animal welfare [42] and/or are 
of economic importance [43], with particular relevance to situations where laboratory 
facilities and funds are limited [44]. Furthermore, the general globalisation of trade of 
animals and animal products has greatly increased the risk of rapid and wide-ranging 
spread of emerging and exotic diseases, requiring timely and efficient ways of dealing 
with diseases that could have catastrophic repercussions for the individual farmer, as 
well as economic implications for the entire country and international trade [45]. In 
situations concerning disease outbreaks, where rapid propagation of infectious agents 
and/or high mortality are salient features, a rapid “animal-side” test would represent a 
critical tool for both collecting surveillance data and for assisting in the control of 
outbreaks [42, 46]. Currently available veterinary POC tests offer a good opportunity 
for a truly “animal-side” diagnosis, but the analytical performances of “on-site” testing 
are still considered limited compared with lab-based testing [47], whilst the possibility 
offered by the support of a central laboratory in the interpretation of the results is still 
perceived as critical [48].  
1.3.2 Point-of-care devices currently available in veterinary diagnostics 
At present, the most widely used technologies for POC testing in veterinary medicine 
are: dipstick tests and lateral flow immunoassays. 
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Dipstick and strip tests are based on the principle of immunoblotting and are made of 
paper strips with pads to analyse specific fluids. After the sample is introduced, the 
results are compared with a colour-coded chart to provide a semi-quantitative 
determination of the analyte(s). The most commonly used are test strips developed for 
human urine analysis, allowing the simultaneous detection or monitoring of leukocytes, 
nitrite, urobilinogen, protein, pH, haemoglobin, specific gravity, ketones, bilirubin 
and/or glucose [49].  While it has been developed for human patients, there is a high 
correlation between the dipstick results and other routinely used methods for urine 
analysis, which has resulted in this test being widely used in small animal private 
practice for first-line diagnosis of chronic kidney disease, mainly through an assessment 
of proteinuria [50, 51]. However, care should be taken when interpreting positive test 
results with low levels of proteins (traces) due to the high rate of false positive results 
[52]. 
A smaller version of the urine dipstick, restricted to detection of glucose and ketone 
bodies, is also largely applied for at-home management of pets with diabetes. This test 
is also widely used in farmed ruminants for the diagnosis of ketosis in cattle [53] and 
pregnancy toxaemia in sheep. Due to some variation in results, a further advance in the 
diagnosis of these diseases is the use of appropriate strips combined with electronic 
hand-held meters to accurately measure both glucose and one of the main ketone bodies, 
ß- bhydroxybutyrate (BHB) in blood, making diagnosis more reliable as well as 
sampling potentially more successful and less stressful [54]. This POC test has shown 
great potential for the quantitative detection of BHB, with improved sensitivity and 
specificity when compared with dipstick tests for detection of ketones in urine or milk 
[55, 56]. Its use for glucose measurement, however, does not seem to be reliable [54]. 
Dipstick tests have also been used for the detection of antibiotics in serum, milk and/or 
meat samples [57]. These rapid tests allow the detection of antibiotics within the µg/ml 
range, permitting on-site monitoring of non-authorised uses of antimicrobials, which 
could be especially useful in slaughterhouses and food processing plants.   
The main advantage of these POC tests is that they can be readily carried out by the 
end-user, proving to be particularly useful for the long term management of chronic 
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diseases [58]. The major limitation, however, can be the subjective interpretation of 
results, based on a personal evaluation of a colorimetric reaction [50]. 
Lateral flow immunoassays (LFIAs) are based on the principle of capillary force: a 
liquid flowing on or through a strip of polymeric material, on or in which specific 
molecules (e.g., antigens, antibodies, DNA/RNA sequence) have been immobilized 
[59]. These strips usually consist of multiple pads: a sample application pad, a conjugate 
pad, a membrane for detection and an absorbent pad (Figure 2), usually made of 
different materials (e.g., nitrocellulose, glass fibre and fused silica) encased in a plastic 
cage for protection of a fragile paper membrane [60]. The best known example of a 
lateral flow test is the pregnancy test [61], which is probably the most used POC test 
worldwide. The main advantages of LFIAs over conventional lab-based tests are their 
simplicity, rapidity and low cost.  
 
Figure 2 - Schematic representation of a lateral flow strip. A liquid sample is deposited on to the 
sample pad, migrating through a conjugate pad and a porous membrane for detection in a final 
absorbent pad. In most strip tests, the appearance of the control line indicates a valid test, while the 
appearance of a second test line indicates a positive result. (Valentina Busin). 
There is a significant market for the use of LFIAs for a range of acute and chronic 
diseases or conditions in companion animals. Some diseases have received considerably 
greater attention, notably viral infection diseases, such as Feline Immunodeficiency 
Virus (FIV) and Feline Leukemia Virus (FeLV) in cats [62] and parvovirus in dogs 
[63], as well as arthropod-borne disease, especially anaplasmosis and dirofilariasis [64-
66] with an extended range of assays being available. For livestock, LFIAs have been 
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focused mainly on illnesses that represent a substantial economic burden and/or serious 
zoonotic or epidemic diseases. Diagnosis of some of the OIE-listed diseases of the 
World Organization for Animal Health, such as Foot-and-Mouth Disease (FMD) [67-
69], Rinderpest [70] and Peste des Petit Ruminants [71] have already been successfully 
translated into LFIAs, In these cases, endemic areas are frequently in developing 
countries, and often diagnosis is not reached due to the prolonged time between 
collection of samples, arrival at the reference laboratory and subsequent testing [72]. 
Finally, LFIAs have also been successfully applied for the detection of food-borne 
pathogens and of fraudulent substances in animal feed or in animal products. In the first 
case, much emphasis is placed on the prevention of serious zoonotic diseases, such as 
the highly pathogenic Escherichia coli O157:H7 [73] or salmonellosis [74], which 
represent a significant and widespread public health threat. In the second case, 
unauthorised drug residues [75, 76] and antimicrobial contamination [77-81] dominate 
the scene, both in terms of research and public attention. Here, an on-site test can be a 
powerful tool for rapid detection and subsequent action, especially when dealing with 
highly perishable products. 
Compared with conventional lab-based tests, LFIAs are considerably less expensive, 
but, due to the different materials required, they are still relatively costly (~ £10 for a 
pregnancy test [60]) for application in low-resource settings [82], and, due to the multi-
step processes involved, manufacturing time is extended, making them less suitable for 
high-throughput production. They usually provide a qualitative or semi-quantitative 
result, and analytical performance is generally poorer than lab-based tests, mainly due to 
reduced sensitivity [63, 83] and the possibility of errors due to testing by untrained 
personnel [33]. When compared with reference laboratory tests, specificity tends to be 
comparable, while sensitivity can be as low as 16%, suggesting that a positive result 
might be trusted, whereas, in the case of negative results, further confirmatory 
laboratory testing may be advisable. Several studies have assessed quantitation, but such 
devices still require instrumentation [84, 85] and trained personnel, and are still limited 
to single analyte testing. 
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1.4 Microfluidic technologies for disease diagnosis 
One of the most promising technologies that has been applied recently in diagnostics is 
microfluidics, which involves the analysis of extremely small amounts (microlitres or 
nanolitres) of fluid using interconnected networks of channels measuring tens to 
hundreds of micrometres [86]. Since the introduction of microfluidics from the early 
1990s [87], there has been a constant evolution of these methods, mainly following 
critical advances in microfabrication technologies [88]. Fluid transport in these devices 
is achieved by either passive (usually capillary forces) or active (generally pumping) 
mechanisms [89, 90], with the fluid flow being typically laminar [91]. 
Among the main advantages of microfluidics technologies for diagnostic applications 
are their portability and their low consumption of reagents; these attributes have made 
these devices inexpensive, rapid and generally easier to use compared with conventional 
(macroscale) testing [92]. The use of very small volumes, associated with shorter 
diffusional distances, results in significantly reduced time for analysis, making 
microfluidic assays significantly more rapid to perform than their macroscale 
equivalents [93]. Furthermore, being able to perform all necessary steps within one 
device and potentially in a single reaction represent a considerable advantage, allowing 
sample pre-treatment, analysis, signal detection and amplification in the same device 
[94]. Automated control of all steps can reduce inherent human error, which in turn 
increases the quality, reproducibility and reliability of assay results. The higher degree 
of control of fluid flow and the timing of binding reactions can also result in 
significantly improved analytical performance [95], while the opportunity for tests to be 
carried out simultaneously offers considerable potential for multiplexing [94]. Examples 
of the successful applications of these new technologies are in the clinical analysis of 
blood [96-98], pathogen identification [99, 100], genetic testing [101, 102], detection of 
environmental contaminants [103] and for drug screening [104]. 
Currently, two main types of microfluidic systems are used in the diagnostic field: 
micro total analysis systems (µTAS) and microfluidic paper-based analytical devices 
(µPADs). However, to date, there has been very limited application of this technology 
in the veterinary field [105]. 
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1.4.1 Micro total analysis systems (µTAS) 
These systems are also commonly known as “lab on a chip” (LOC) devices (Figure 3), 
which use fluid as a working medium and can integrate a number of different 
functionalities on a micro scale [88]. One of the main advantages of µTAS is that they 
allow for all steps (from sample pre-treatment to signal detection) to be carried out at 
once, on the same device, allowing complicated molecular techniques (i.e. polymerase 
chain reaction (PCR)) to be transferred on the chip for POC testing. These devices are 
fabricated using techniques from the microelectronics industry [106], mostly using 
materials, such as silicon, glass and/or polymers (e.g. PMMA or PDMS) [107]. At 
present, the most common materials used are thermoplastic polymers. These devices 
have reduced production costs, and have suitable mechanical, chemical and thermal 
properties [108]. 
Their diagnostic use is well established, with companies already commercialising POC 
devices on plastic platforms [109]. In the last decade, there has been a considerable 
focus on immunodiagnostic tests for the detection of disease markers, specifically for 
cardiac and cancer markers [110-113] and for the diagnosis of infectious diseases, 
including HIV/AIDS [114, 115], influenza [116] and hepatitis [117]. Some limitations 
of these devices are inherent in their physical effects, such as the need for pressure-
driven liquid flow, with the possible consequence of heat generation and, therefore, 
detrimental effects on biomolecules, or low grade mass transfer and/or reduced mixing 
capacity [88]. 
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Figure 3 - Stand-alone, self-powered integrated microfluidic blood analysis system (SIMBAS). A) The 
microfluidic platform integrates plasma separation from whole-blood with multiple immunoassays. B) 
Cross section of the device: fabrication materials (1); storage of the device in a vacuum package (2); 
addition of 5ml of whole-blood sample on the inlet, degas-driven flow propels the sample into the 
device (3); blood cells sediment gravitationally and are filtered, while plasma flows into the channel 
(4); detection of multiple biomarkers (5); the flow is stopped by the suction chamber (6). Reprinted 
with permission from [98]. Copyright (2010) Royal Society of Chemistry. 
Chapter 1– Introduction 
14 
1.4.2 Microfluidic paper-based analytical devices (µPADs) 
These devices are commonly referred to as paper-based microfluidics (Figure 4), a 
concept that has been extensively explored by the Whiteside group at Harvard 
University and the Yager group at University of Washington, following on from initial 
research performed on paper strips for the determination of pH [118].  
 
Figure 4 - 3D origami-based microfluidic paper based analytical device. A) Schematic representation, 
size and shape of the 3D origami-based device. B) The front and back surface of the device. C-D) 
Binding of a baked thin wax-patterned blotting paper on each waste tab, front (C) and back (D). E-F) 
Binding of an unbaked thick wax-patterned blotting paper on each waste tab. The assay procedure is 
carried out by folding the different tabs above the test pad and adding the reagents sequentially, with 
the aid of a customised device folder. Reprinted with permission from [119]. Copyright (2012) Royal 
Society of Chemistry. 
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Paper has considerable advantages over other materials in that it is cheap, easy to 
source, biodegradable and naturally abundant, but also simple to modify chemically 
[120]. POC devices made from paper also have the advantage of not requiring external 
power sources, whilst fabrication techniques and machinery for production are usually 
less expensive than those for other materials, with minimal technical expertise required 
[121]. Paper represents an excellent medium for diagnostic testing, due to its high 
surface to volume ratio, which allows reagents to be concentrated, enabling more rapid 
reaction times [122]. Surface-chemical properties characteristic of paper mean it does 
not swell with water and has high surface energy, with increased absorption properties 
[123].  
Although µTAS are renowned for being less expensive than conventional lab-based 
testing, materials such as glass and silicon can still be considered expensive, either in 
terms of their environmental footprint or in their production costs [94]. Therefore, one 
of the main advantages of choosing µPADs over µTAS as a diagnostic platform is their 
further reduction in cost. µPADs are also considered to be “easier” to produce, with no 
requirement for valves or pumps, as they use capillary force to move fluids within the 
device [121]. However, there can be issues with sample retention and evaporation, 
making them less suited to the analysis of small volumes [124]. These devices allow 
inexpensive multiplexed analyses to be carried out [125], while maintaining the 
advantages of conventional microfluidic technology, such as size, speed and reduced 
sample volumes [38]. 
The most widely used types of paper to fabricate these devices are chromatography 
[126-128] and filter paper [129, 130]. These types of paper are made 100% from cotton, 
where fibre molecules are closely packed and parallel to one other, which result in high 
degree of reproducibility and uniformity [131], as well as being highly hydrophilic. 
They also have a white colour, which represent an important factor in image analysis. 
Fabrication of µPADs is based on the construction of hydrophobic barriers/walls to 
physically separate hydrophilic zones, preventing cross contamination. At present, ten 
different techniques have been described in the literature for the fabrication of paper-
based microfluidic devices: photolithography [132, 133], PDMS printing [134], ink jet 
Chapter 1– Introduction 
16 
etching [60, 130], plasma treatment [135], wax printing [136-139], modified ink jet 
printing [140-142], flexography printing [143], screen printing [139], laser treatment 
[144] and paper cutting [127, 145, 146]. Among these, the wax printing method has 
become the most frequently used process for fabrication of µPADs. Using a wax-based 
ink printer, the wax is deposited onto a paper surface, then heated on a hot plate to melt 
the wax, generating hydrophobic areas. Although it represents a low-cost technique and 
it is a reasonably user-friendly method [137], it can be unstable at high temperatures 
[147], making it less suitable for long-term storage, especially in developing countries 
and it can also suffer from poor channel resolution [82]. Methods based on two-
dimensional cutting, have been proposed has a valid alternative to the physical 
deposition of hydrophobic materials, as they are suitable for mass production and 
require less instrumentation. In this case, a computer-controlled  knife plotter [146] or a 
CO2 laser [148] is employed to physically remove paper and create microchannels and 
reaction zones. The main challenge in this case, is represented by the necessity to 
provide a robust support for the shaped paper, which can result in high-cost of the 
device [147]. 
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1.4.2.1 P-ELISA 
Within the field of µPADs, a very interesting application has recently been 
demonstrated in the translation of ELISA onto paper or P-ELISA [122]. P-ELISA 
combines the sensitivity and specificity of ELISA with the intrinsic low cost and ease-
of-use of paper-based platforms [149]. There are increasing numbers of studies 
reporting the use of P-ELISA as a valid alternative to the conventional format [150-
154].  
 
Figure 5 - 96-zone paper plate produced using photolithography after application of a range of 
volumes (1 to 55 μL) of coloured dye solutions.  Reprinted with permission from [122]. Copyright 
(2009) American Chemical Society. 
The conventional lab-based ELISA has substantial drawbacks in terms of cost and time. 
It needs dedicated instrumentation (a plate reader and a plate washer), it requires large 
volumes of reagents (usually 200-300µl) and it necessitates extending incubation time 
between steps (typically around 1hour). In the case of P-ELISA, 96-zone plates are 
created using the same techniques described for µPADS, with the additional possibility 
of custom-made format to widen the range of tests that can be performed and maximise 
the output [122]. Stages are comparable to those in the lab-based ELISA, where a 
capture molecule is immobilised within the paper substrate, a sample is incubated onto 
the platform and a detection reagent is used to visually assess the presence of the 
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analyte of interest. The most common detection method for P-ELISA is colorimetric 
[131, 151, 152, 155, 156], which allows for either visual detection by eye for qualitative 
measurement [157] or image analysis for quantitative measurement, with the option of 
using either a desktop scanner [151] or, even more appealing for POC application, a 
digital or a smartphone camera [150]. Other options include the use of 
chemiluminescence [154] and electrochemical methods [158], although they would 
require special instrumentation. Overall, the main advantages of P-ELISA are the 
significant reduction in cost, which can be around £6 [159] and time, which is usually 
below one hour. 
While sensitivity is still about a magnitude below that normally expected from lab-
based ELISA [152], nonetheless its potential for future application in the field at high-
throughput and low cost is significant.  
1.4.2.2 3D microfluidic paper-based analytical device (3D µPAD) 
A further development in the concept of µPADs, has recently been introduced with the 
creation of 3D paper-based microfluidic devices. The main advantages are the 
possibility of multiplexing [119], the reduction in steps done by the operator [160] and 
the more rapid distribution of the sample [161], by having fluid moving in a vertical 
direction. At the moment, two main fabrication methods for these devices are reported 
in literature. One is to bond each patterned paper layer to the next, by using double-
sided adhesive tape [160, 162, 163], adhesive spray [161] or thermal adhesive [164]. 
They allow for multiple layers (up to 8) to be contained in one device, but some might 
need cellulose powder [162] or hydrophilic material [165] to reduce the gaps between 
layers or require very high temperature for bonding [164], which could destroy heat 
sensitive reagents. The other one is based on the origami technique, where layers are 
folded together and hold in place with custom-made holders [119, 166, 167]. This 
method allows for direct contact between layers, but requires the fabrication of 
additional material. These devices have been used mainly for simple assays, like 
detection of glucose and protein [131, 161, 162, 164, 168], but recently some devices 
have been successfully employed for more complicated immunoassay, such as 
multiplex detection of cancer markers in whole blood [119], a sandwich ELISA for 
pregnancy diagnosis [163] and an indirect ELISA for IgG detection [165].  
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There is great scope in this research field to integrate these new platforms with more 
complex laboratory techniques, such as nucleic acid amplification [169, 170], DNA 
extraction [171] or whole blood analysis [172]. Focus should also be placed on enabling 
these devices to become truly POC, by taking advantage of the technologies already in 
place for remote and cost efficient diagnosis [173, 174] as well as on increasing 
commercialisation [175], in order to reach those at the end point and make a real 
contribution in advancing healthcare for both human and veterinary medicine. 
1.4.3 Challenges for the application of microfluidic technologies in point-of-care 
veterinary diagnostics 
One of the biggest challenges in the field of microfluidics is the translation from 
academic research to end-user products [176]. While the field of microfluidics has seen 
an exponential development in recent years, the launch of a commercialised platform 
that would revolutionise the concept of microfluidic technologies is still lacking [177]. 
Unfortunately, the fact that the diagnostic field is already quite mature, makes it harder 
to find companies willing to invest in new areas [147], and the difficulties in changing 
people’s attitudes toward testing can represent an additional hurdle, especially when 
methods have been in place for many years. In this respect, the perception that 
analytical performances are still inferior to conventional lab-based tests remains a 
considerable constraint to the uptake of these technologies [33]. However, there is 
evidence that when a rapid result can achieve a better treatment rate, the sensitivity of a 
test can play a less important role [178]. This situation is extremely applicable in the 
veterinary field, where owners may struggle to find time for follow up visits after a test 
has been performed, or it may be problematic for farmers to re-gather animals days after 
testing [179]. Furthermore, as already in place for instrumental veterinary POC testing 
[180], specific guidelines should be put in place for the quality assurance of newly 
developed POC tests, in order to provide a consistent and practical approach to 
evaluating their performance and increasing veterinarians’ confidence in test results 
[181].  
While some of the challenges faced in human healthcare have been addressed by the use 
of microfluidic technologies, this is not the case for animal health-related areas. For 
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example, although the use of microfluidic technologies is suited for telemedicine, the 
handling or recording of data needs to be carefully organised. Data management 
systems are available for POC [182], which allow for valuable information to be stored 
and made available in real time. However, in the case of notifiable diseases, like the 
case of sheep scab, specific rules and strict controls will be required to ensure that 
legislation is followed. 
1.5 Aim and objectives of the research 
The overall aim of this highly interdisciplinary project, based on the close collaboration 
between the Moredun Research Institute and Heriot Watt University, is to develop a 
low-cost, multiplexed, pen-side diagnostic test for sheep scab, combining detection of 
serum antibody (IgG) specific to the mite antigen, Pso o 2, with the detection of a 
previously characterised serum biomarker (Hp), using microfluidic paper-based 
analytical devices. Once developed, this diagnostic platform could potentially be 
applied to other veterinary disease models where diagnostic assays are available (e.g. 
Maedi-Visna/Caprine Arthritis Encephalitis, Enzootic Abortion of Ewes etc.), 
representing a very interesting option for the end-user (both veterinarians in practice and 
farmers) as it could overcome some of the major constraints surrounding farm animal 
diagnostics (mainly cost and time).  
The specific project objectives are as follows: 
• To develop a simple and effective fabrication technique for high-throughput 
production of microfluidic paper-based analytical devices, based on paper 
cutting and lamination methods.  
• To translate and validate the individual immunoassays for diagnosis of sheep 
scab (Pso o 2 and Hp) from the conventional lab-based format onto a paper-
based microfluidic test platform (P-ELISA). 
• To develop and fabricate a working 3D microfluidic paper-based analytical 
device (3D µPAD), based on the previously developed fabrication technique. 
• To incorporate the individual assays into a single multiplexed platform on the 
developed 3D µPAD. 
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Chapter 2 – Experimental techniques  
2.1 Introduction 
In this chapter, the experimental techniques used throughout the thesis are explained. 
Experiments were performed at the Institute of Biological Chemistry, Biophysics and 
Bioengineering of Heriot-Watt University for the fabrication of the microfluidics paper-
based analytical devices (µPADs) and at the Moredun Research Institute (MRI) for the 
analysis of samples. If materials or techniques different from the ones reported here 
have been used at any point in the experiments, they will be reported in the 
corresponding chapters. 
2.2 Ovine serum samples 
2.2.1 Clinical samples 
To validate the paper-based diagnostic tests, serum from naïve sheep and from sheep 
with known degrees of sheep scab pathology were used. Serum samples were sourced 
from sheep kept at the MRI for the maintenance of a P. ovis mite colony (Figure 6). A 
total of 8 animals were sourced from a non-infected flock. Following experimental 
infestation with a bolus of approximately 20-50 P. ovis mites placed directly on the 
withers, animals were euthanized at 6 weeks post-infestation. Whole blood samples 
were collected by jugular veni-puncture before infestation and at weekly intervals for 6 
weeks. A total of 52 data points was analysed by ELISA (8 animals from which serum 
samples were obtained over 7 time points). 
After collection, samples were left at room temperature for 30 minutes for blood 
clotting. Samples were then centrifuged at 2000rpm for 10 minutes and serum was 
collected using Pasteur pipettes. It was then aliquoted in 200µl and stored at -20°C in 
1.5ml plastic micro centrifuge tubes. Serum was thawed at room temperature prior to 
analysis and unused samples were discarded. 
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Figure 6 - Sheep kept within the MRI premises to maintain a mite colony. Serum samples from these 
animals were used for this project. 
2.2.2 Positive and negative control serum samples 
Serum samples used as positive and negative controls for the commercial Pso o 2 
ELISA were also available. These samples had been sourced from non-infested sheep 
(n=6 MRI) and from terminal bleeds from experimentally infested sheep (n=6 MRI). 
They were used for the optimisation of the Pso o 2 indirect P-ELISA and in the form of 
pooled blood samples, as positive and negative controls for the analysis of clinical 
samples for both the lab-based ELISA and the P-ELISA. 
2.3 Lab-based ELISAs technique and reagents 
The lab-based ELISA protocol for detection of Hp in bovine and sheep serum samples 
is reported in Appendix A (Chapter 8). 
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The lab-based ELISAs for detection of Pso o 2 antibodies was carried out by Dr. 
Francesca Nunn, at MRI for all the animal samples used in this project. The protocol 
used is reported in Appendix B (Chapter 9). 
Reagents used for both P-ELISAs were sourced and prepared as reported in the 
Appendixes. Further reagents used for the indirect Pso o 2 P-ELISA and not reported in 
the Appendixes were as follow. Bovine serum albumin (BSA) (Sigma Aldrich, USA; 
Catalogue No A9647) and gelatin from cold water fish skin (fish gelatin) (Sigma 
Aldrich, USA; Catalogue No G7765) were used to prepare blocking buffers. 
2.4 Fabrication and performance testing of the microfluidic paper-based 
analytical devices 
A new fabrication technique for µPADs was developed within this project and 
implemented for all paper-based devices reported in this thesis. Devices were fabricated 
using a paper cutting and lamination technique. Paper and lamination sheets were cut in 
the desired format and then laminated to produce the final device. The basis for this 
technique had been inspired by work from the Yager group [1, 2], where sophisticated 
paper networks where fabricated using a CO2 laser, which represented a user-friendly 
procedure, requiring minimal training and easily available machinery. The major 
drawback of these devices was the requirement for external support for the wet paper 
(double-sided tape on a glass substrate). A possible alternative to maintain the low-cost 
and ease of production is the use of lamination [3, 4]. The combination of these two 
procedures formed the foundation of the new technique developed herein. 
2.4.1 Design of the microfluidic paper-based analytical devices 
A 3D mechanical computer-aided design (SolidWorks 2012x64 edition, USA) was used 
to design both the paper devices and the plastic lamination used for device packaging. 
The designs where based on 2D engineering drawings and for creation of the 3D µPADs 
(Chapter 6), a 3D arrangement of parts was used. The designs were then exported as 
.DXF files into CorelDraw for processing by the laser system (Figure 7). 
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Figure 7 - Design process for production of µPADs. A) Drawing using a CAD program. B) After 
saving as a .DXF file, CorelDraw was used for final adjustments and the print panel was used to 
process the design by the laser system. C) The laser system software with the panel for cutting settings. 
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Using CorelDraw, selected areas of the design can be assigned different colours, which 
can be processed by the laser at different settings or at different times (Figure 7C). This 
facility was utilised to make a single design incorporating both the paper and the 
lamination cutting, which were fabricated at different times. It also allowed for settings 
to be optimised and compared at the same time. 
2.4.2 Paper and lamination sheets 
Cellulose chromatography paper (Whatman grade 1, Sigma-Aldrich, UK) was used 
throughout experiments. The main characteristics of this paper are an 88 g/m² basis 
weight, 180 µm thickness and 11µm pore size (medium fluid retention), with a linear 
flow rate (water) of 130 mm/30 min (medium flow). Lamination sheets (Staples, UK) 
were 75µ gloss lamination pouches (commercially available lamination sheets with the 
lowest thickness where chosen, to minimise the space between layers for the creation of 
the 3D µPADs). A considerable number of paper-based devices have used the same type 
of paper [5-9] and interesting recent work has also been carried out comparing the 
characteristics of different types of paper [10], showing that chromatography paper 
Whatman no. 1 is an ideal matrix for paper-based microfluidic devices.  
2.4.3 CO2 laser cutter 
A class 2 carbon dioxide (CO2) laser cutter (Trotec Speedy 300 Laser Engraver) was 
used to cut both the paper and the lamination sheets (Figure 8). The optimised settings 
for cutting both materials were: power 4%, speed 0.4, PPI/Hz 1000, passes 1, air assist 
on. These settings were chosen as the best combination for fast and precise production, 
while avoiding material burning. 
 
Figure 8 - Class 2 CO2 laser cutter. A) Trotec Speedy 300 Laser Engraver. B) The inside of the laser. 
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2.4.4 Lamination 
Paper devices were assembled within the pre-cut lamination sheets and lamination was 
performed using a roll laminator (GBC Catena 35 Roll Laminator) (Figure 9). Settings 
for lamination were: 110°C, at the lowest speed (1) and with rollers set at 1mm gauge 
distance. 
 
Figure 9 - GBC Catena 35 Roll Laminator. 
2.4.5 Performance testing 
To assess the performance of the fabricated devices (complete wet out, flow rate and 
mixing), food colours were used through the experiments. Morrisons Ltd. Natural Food 
Colouring Blue, Green, Yellow and Red were used, all diluted 1:10 with tap water. The 
prepared colour solutions were applied to the devices with a pipette. 
2.5 Image and statistical analysis  
Images of the paper devices were taken using a desktop scanner (Epson Perfection 
V350 photo) set to “colour photo scanning” and 1200 dpi resolution. Images were 
transformed in 8-bit greyscale with PixBuilder Studio 2.2 (WnSoft Ltd., UK) and mean 
grey value (mean pixel intensity) was measured with Image J (1.48v, National Institute 
of Health, USA), after image inversion and after selection of the area to be measured 
(Figure 10). 
Data were saved as Microsoft Excel 2007 files and data analysis was carried out with 
the statistical package GraphPad Prism 7 (GraphPad Software, Inc., USA).  
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Figure 10 - Image analysis. A) Image of a paper-based device taken using a desktop scanner. B) Image 
transformed into grayscale. C) Image analysed with Image J, after image invert and after oval 
selection of the area to be measured. Results show measurement in mean grey value. 
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Chapter 3 – Development of a multi-pad paper plate (MP3) for P-
ELISA 
3.1 Introduction 
The conventional methods used for fabrication of P-ELISA platforms involve 
photolithography [1] and wax printing techniques [2-7]. The first is based on the 
physical blocking of pores with photoresistant chemical substances (SU-8 photoresist) 
and requires a UV light, a hot plate and a transparency mask with the desired patterning 
design. The main drawbacks are the numerous steps involved for production of the final 
device, including impregnation of the paper with the photoresist, baking, cooling, 
exposure to UV light using the designed mask, a second baking and cooling step, 
bathing and rinsing in acetone and isopropyl alcohol and a drying time of at least one 
hour [8] and the cost of the photoresist [9]. The second is based on the physical 
deposition of reagents (wax) onto the paper surface and requires a solid-ink printer and 
a hot plate or oven. It involves deposition of wax on paper, following a pre-design 
patterning template, and a heating step for the wax to melt into the paper. Although 
much cheaper than photolithography, it suffers from poor channel resolution [9]. To 
overcome some of the drawbacks of these methods, specifically to maintain low-cost 
and simplicity of production, while offering precise microchannels fabrication, an 
alternative method of production could be based on combining paper cutting techniques 
to create the desired patterns [10, 11] with lamination [12] to provide the required 
robustness to the final device. Although these techniques have been exploited in the 
fabrication of paper-based devices, none has been specifically applied to P-ELISA 
platforms. 
The aim of this chapter was therefore to develop a new and suitable alternative 
technique to produce a paper-based platform for P-ELISA, based on a combination of 
paper cutting and lamination. The experiments were focused on the reproduction of a 
conventional plastic 96-well microplate, commonly used for ELISA, but with paper as a 
substrate material. The research question was aimed at demonstrating that the new 
technique could solve some of the intrinsic limitations of the other two techniques 
reported (e.g. cumbersome production and low-resolution technique), while maintaining 
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low cost of fabrication and rapid production. The development of this platform, termed 
herein multi-pad paper plate (MP3), including the main challenge in assuring complete 
independency of the paper pads and further possible applications, are described and 
discussed in this chapter. The techniques developed in this chapter also form the 
foundation for the development of the devices reported in Chapter 6. 
3.2 MP3 design and fabrication 
3.2.1 Initial design 
Different prototypes (a total of 10) were designed and tested before the final MP3 device 
was finished, all based on the final aim of enclosing 96 circular paper pads. Initially a 
simple single row of 5 circular paper pads (5mm diameter) was used (Figure 11). The 
main function of this prototype was to test the production system for robustness and 
deposition of samples (e.g. serum) on the circular paper pad. Furthermore, the first 
prototype allowed for paper cutting and lamination settings to be optimised (optimised 
settings described in Chapter 2), by reducing the material and time required before 
committing to a more complicated structure. The main learning point of these initial 
prototypes, was the need for laminated sheets to be cut on both sides, to allow for 
washing steps to be carried out effectively. Therefore, all following prototypes and the 
final device, used lamination sheets cut on both sides. 
 
Figure 11 - First prototype of the paper-based device. The prototype consisted of 5 circular paper pads 
enclosed in a lamination pouch and laminated. Lamination pouches were cut on both sides. 
The prototypes also used different lamination dimensions, in order to determine the 
minimum lamination surface needed to cover the paper for uniform lamination (circle 
centred within the lamination sheets) and to provide sufficient robustness, while 
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maximising the analytical surface available. A difference of 2 mm diameter between 
paper and lamination was deemed to provide the desired results (Figure 12). 
 
Figure 12 - Different lamination sizes. Difference between paper and lamination diameters: 1mm (a), 
2mm (b) and 3mm (c). 
3.2.2 Design to replicate a 96-well microplate 
Further experiments were designed to replicate a 96-well microplate. These plates are 
generally used to perform ELISA and common instruments used in the lab (e.g. 
multichannel pipettes and washing manifolds) are designed to fit these measurements. 
The bottom of a 96-well microplate is 8mm diameter, with an intra-well spacing of 
9mm. Based on these measurements, a first design was produced to recreate the same 
measurements as a standard 96-well microplate (Figure 13) with a 2 mm diameter 
difference between paper and lamination. 
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Figure 13 - Design to reproduce the measurement of a standard 96-well microplate. Black drawings 
represent the paper cutting (8mm diameter), red drawings are the lamination cutting (6mm diameter) 
and the green line represents the in-between wells space (9mm). 
3.2.3 Assembly of the device 
The major obstacle encountered with this new technique of paper cutting and 
lamination, was device assembly. The initial prototypes based on 5 circular paper pads, 
allowed for paper pads to be fitted manually with the help of tweezers (Figure 14).  
 
Figure 14 - Manual positioning of paper pads within the device. A) Paper pads were positioned within 
the lamination circles with the aid of tweezers. B) After all the circles were enclosed within the two 
lamination sheets, paper pads were centred with tweezers. 
This technique was not possible for the final design, as manually fitting 96 pads would 
be extremely time consuming and highly likely to result in human error with inter-batch 
variability (Figure 15). 
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Figure 15 - Device created by manual assemble of 96 paper pads. Red square highlighting misaligned 
pads within the lamination.  
Consequently, different solutions were considered.  A smaller version of the 96 circular 
pads was designed and used to test different options, as well as to reduce material 
consumption and time. The design was therefore reduced to 4 circular pads with the 
same measurements for both paper and lamination. Three different options were tested. 
Initially laser settings were changed to obtain incomplete cutting of the paper. Power 
was reduced from 4% to 2.5% (all other parameters were kept the same) to change from 
cutting to etching of the paper. This resulted in the circular pad being still physically 
attached to the original paper sheet (Figure 16A). Although this prototype was very easy 
and quick to assemble, it resulted in fluid leakage between pads when tested with food 
colouring (Figure 16B). 
 
Figure 16 - Testing of different assembly options using modified laser settings. A) The power of the 
laser was reduced to 2.5% to obtain an incomplete cut of the paper. B) When tested with food colouring 
(10µl), leakage of fluid from the pad into the paper sheet and the next pad was observed. 
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A different approach, with complete cutting of the paper except for 4 contact points 
maintained between the pad and the original paper sheet showed the same problem 
(Figure 17). Although still unsuccessful, this approach suggested that maintaining a 
connection between the paper pads was necessary for easy assembly with this 
connection then being severed to produce the final device. 
 
Figure 17 - Testing of different assembly options using a modified paper design. The paper was cut 
using the optimised settings, but the design was changed to leave 4 limited areas (0.2mm each) where 
the paper was not cut. When tested with food colour (10µl), leakage of fluid from the pad into the 
paper sheet through the 4 connecting areas was observed. 
An alternative and novel approach was to create a matrix with interconnecting 
microchannels between pads and after assembly (which is fast, easy and repeatable) 
channels were severed using a laser cutter. The resulting device demonstrated that the 
approach was capable of producing independent pads and required minimal time for 
assembly (Figure 18A), however the proximity of the pads made the precise severing of 
the microchannels inconsistent, which could result in some pads within the device not 
being completely separated (Figure 18B). 
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Figure 18 - Testing of different assembly options using microchannels. The design was changed to 
create interconnecting microchannels which allowed manual fitting of the device within the lamination 
sheet. After lamination, the device was placed in the laser once more and the microchannels severed. 
A) When food colouring (10µl) was applied, there was no evidence of leakage. B) Evidence of fluid 
leakage when severing of the microchannels between pads was not complete. 
Therefore, a new design, with smaller pads (6mm diameter), but with the same inter-pad 
distance was created. The design also included small rectangular shapes for severing of 
the interconnecting microchannels (Figure 19). 
 
Figure 19 - Final design and measurements for the MP3. Black drawings represent the paper cutting 
(6mm diameter), red drawings show the lamination cutting (4mm diameter) and yellow lines show the 
severing of the interconnecting microchannels (0.5x3mm). 
One of the challenges related to this approach, was the difficulty in the precise re-
alignment of the laser to cut in between the pads and within the connecting channel. 
Initially, re-alignment was done manually, which was time consuming and subject to 
human error (Figure 20).  
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Figure 20 - Manual re-alignment of the MP3. After manual re-alignment of the device in the laser, as 
shown in the red square, some channels were not correctly severed. 
A more efficient and precise approach was taken, by selecting a specific point within 
the design (the chosen point was the centre of the first paper pad) and, using the 
corresponding location within the file, the laser beam was directed at the same location. 
The x and y coordinates from CorelDraw were subtracted to the x and y coordinates on 
the laser position, the laser beam is therefore centred on the middle of the first paper pad 
(Figure 21), resulting in the microchannels being precisely severed in the middle, 
requiring minimal timing for alignment and high reproducibility. 
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Figure 21 - Calculation process for the exact re-alignment of the laser to obtain precise severing of 
microchannels. A) The coordinates on the design file (CorelDraw) for the centre of the first paper pad 
were calculated: x=8.5mm, y was calculated as the difference between y of the file dimension (258mm) 
and y of the first paper pad (249.5mm), corresponding to y=8.5mm. B) The calculated coordinates 
(x=8.5 and y=8.5) were subtracted from the laser position (x=53.27 and y=26.76) and the value was 
entered into the job position (x=45.22, y=18.26). The result of calculating and subsequently re-
directing the laser beam, was the exact alignment of the laser with the first paper pad. 
 
Chapter 3– Development of a multi-pad paper plate (MP3) for P-ELISA 
58 
3.2.4 High-throughput fabrication of the device 
One of the most important features to allow future application in commercial settings of 
the designed platform, was to achieve large scale high-throughput fabrication. In this 
case, the production of one MP3 took an average of 10 minutes. Although still within 
experimental settings, it was possible to reduce the production time to just over 3 
minutes per MP3 by modifying the CAD design to fit 3 devices in a single A4 sheet. 
This allowed 3 paper and lamination sheets for the MP3 to be cut at the same time and 
once assembled and laminated as one, the A4 sheet containing the 3 devices was placed 
back into the laser for final severing of the interconnecting channels. During this final 
step, a simple modification of the CAD design allowed each device to be easily 
detachable from the A4 sheet. The final cut-out of the device was assigned a different 
colour and a different style (from continuous line to dotted line) and, due to the 
precision of the laser beam, a single point laser cut was achieved. The devices were 
therefore still attached to the laminated A4 sheet, but could be easily peeled off and 
ready to be used once all devices within the sheet were cut (Figure 22). 
 
Figure 22 - The MP3 can be peeled off from the lamination sheet ready for use. 
3.2.5 Built-in information on the device 
A further modification of the design, allowed for plate information including numbers, 
letters and other information to be cut or engraved on the final device (Figure 23). This 
Chapter 3– Development of a multi-pad paper plate (MP3) for P-ELISA 
59 
did not require changes to the original CAD file, but the desired information was added 
on the CorelDraw file and applied to the final process (laser cutting of interconnecting 
microchannels) as needed. 
 
Figure 23 - Letters and numbers cut on the laminated device. 
3.3 Final MP3  
The final MP3 consisted of 96 circular paper pads of 6mm diameter connected by 
microchannels of 0.5mm width and 3mm in length (Figure 24A) and a complementary 
lamination sheet of 96 circular holes of 4mm diameter (Figure 24B), assembled in the 
pre-cut lamination sheet (Figure 24C) and laminated (Figure 24D). After lamination, the 
laminated MP3 was placed back into the laser and the connecting microchannels 
between pads were severed (Figure 24E), making each pad completely independent 
from the others. Numbers (1 to 12) and letters (A to H), normally present on 96-well 
microplates for referencing, where also cut on the device. The final device was tested 
with food colouring for determination of the optimum volume of liquid to allow 
complete wetting of each paper pad. A range of 1 to 50µl were applied to the platform 
(Figure 24F), showing that the fluid volume was 2µl, which allowed complete wetting 
whilst minimising drying time. 
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Figure 24 - Schematic of the fabrication of the MP3. A) Paper cut with a laser cutter. B) Laminating 
pouches cut with a laser cutter. C) Assembly of device in the pre-cut lamination sheets. D) Lamination 
of device. E) Severing of interconnecting paper channels by laser cutter. F) Application of food colour 
to the device. Numbers represent volume of fluids applied (μl). For this procedure, the MP3 was placed 
on top of a 96-well microplate for support. 
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The MP3 was also tested with commonly used laboratory instruments (Figure 25). 
 
Figure 25 - MP3 tested using common laboratory instruments. A) 8 Multichannel pipette. B) 96 well 
vacuum manifold for automated washing. 
The cost of the materials for production of a single MP3 was calculated to be £0.27 (cost 
of £40 for a pack of 100 chromatography paper sheets and £20 for a pack of 50 
lamination sheets, which would both produce 3 devices/sheet). 
3.4 MP3 fabricated with different types of paper 
Although different grades of filter and chromatography paper are available, comparison 
of their properties in relation to the immunological assay is not routinely performed. 
The new technique also allowed different types of paper with different pore sizes to be 
incorporated into one MP3. The CAD design was modified to include 3 different types 
of paper in a single device, by removing the interconnecting microchannels at every 4th 
column. In a set of experiments, WHT 4 (Whatman filter paper, Grade 4, pore size 20-
25µm) and WHT 597 papers (Whatman filter paper, Grade 597, pore size 4-7µm) where 
directly compared to the standard paper used in the previous experiments (WHT 1, 
Whatman chromatography paper, Grade 1). To compare the light transmission through 
different types of paper, a transilluminator (Alpha Imager™ 2200), set at 
“transilluminator” mode, with 1 second exposure was used and images were analysed 
using Image J as described in 2.5. 
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By the naked eye, it was not possible to appreciate any visible differences between the 3 
types of paper. However, when pixel intensities were compared, there were highly 
significant differences (p<0.0001) between the 3 paper types (Figure 26). 
 
Figure 26 - Comparison of light transmission through different paper types. WHT1: Whatman 
chromatography paper grade 1, WHT4: Whatman filter paper grade 4, WHT 597: Whatman filter 
paper grade 597. A) Boxplot of grey intensity values (n=32), showing the mean, min and max values. 
*= p<0.0001 by One-way ANOVA and t-test to compare each set of papers. B) Images taken from the 
transluminator showing light transmission through the different types of paper. 
3.5 Modified MP3 to enable for multiplexed testing 
To further reduce consumption of the reagents and/or sample material, as well as 
timings, a multiplex format of the conventional 96-well microplate could be produced, 
allowing for one sample to be simultaneously tested for multiple markers/diseases (up 
to 4 per sample). Using the methods described above, it was therefore possible to 
produce a different version of the MP3 with 480 pads, by having each of the 96 central 
pads connected to 4 smaller pads (Figure 27). Again, a simple variation of the original 
CAD design was used to generate the modified MP3. First, the in-between pad distance 
for each row was increased from 9mm to 14mm. Then each pad (diameter was kept the 
same) was converted into a central pad with 4 microchannels (1mm width x 0.72mm 
length), each connecting to a smaller lateral pad (2mm diameter). Lamination design 
was modified accordingly, with lamination for the smaller paper pads of 1mm diameter. 
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Figure 27 - Modified MP3 to enable for multiplexed testing. The device comprises 480 paper pads: 96 
central paper pads each connecting to 4 smaller paper pads (2mm diameter) via paper microchannels 
(1mmx0.72mm). 
3.6 Discussion 
In this chapter, a novel fabrication method to create a paper-based platform for P-
ELISA is described. This method was proven to be low-cost, rapid and simple to 
produce. A laser cutter and a laminator are required, but no other specialised machinery 
or clean room facilities are needed. Class 2 laser cutters are easily available within 
Universities and are often employed for other paper device fabrication methods, where 
masks or other devices are usually needed [8, 13, 14]. Computer-controlled knife 
plotters have also been used for production of paper-based devices by paper cutting, but 
three sequential overlapping cuts where needed in order to precisely cut the 
chromatography paper without tearing [10]. The use of a laser cutter provided precise 
cutting without tearing or burning of the paper substrate with only a single pass of the 
laser (Section 2.4.3). Although a professional laser machine was employed in this case, 
commercially available CO2 laser cutting machines could potentially be used, which 
have a similar price to solid-ink printers, commonly used for wax printing of paper-
based devices. Furthermore, the wax printing technique lacks the high resolution 
achieved by other methods (e.g. reduction of the hydrophilic circle diameter from 
approximately 5.56mm to 3.8mm before and after melting [7]), due to the wax 
spreading by capillary action [15]. In this case, dimensions are the same from design to 
production of the final device and a resolution of 200µm (Figure 17) could be achieved. 
Although precision may not be the priority for P-ELISA platforms, it is the case for 
more complicated designs, like 3D paper-based devices. Moreover, wax is soluble in 
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organic compounds, which would have made this platform unsuitable for reagents 
solubilised in urea, as is the case for the recombinant Pso o 2 antigen, used in the sheep 
scab diagnostic test [16]. This new fabrication method also eliminated the need for 
chemical treatments as required by another method of fabrication, photolithography, 
which can pose health and safety issues and increase the overall costs of fabrication 
(estimated cost of commercial SU-8 is $2.00/plate [8] vs an estimated cost of 
$0.4/MP3). Additionally, lamination affords extra strength, which makes these devices 
more robust but still foldable and bendable. 
Another considerable benefit of this technique is the high degree of flexibility when 
designing a new device. Different prototypes can be created from easily made changes 
to the original CAD file, without requiring purpose-built devices (e.g. masks), which 
allows for different conditions and/or parameters to be tested in a cost and time efficient 
manner. A practical example is the modification of the MP3 from 96 to 480 paper pads, 
made possible because of the high degree of precision and the extreme flexibility of this 
technique. A possible application of this modified MP3 would be to have multiple tests 
performed on a single serum sample at the same time (e.g. 4 tests per sample). 
Multiplexing has been shown to reduce cost, time and sample use [17], which makes it 
an attractive option for disease diagnostics. It could also be used to increase the 
information available, in order to obtain a more accurate diagnosis [18]. Applications in 
veterinary diagnostics would be of particular benefit in cases where multiple agents are 
involved, like for abortion outbreaks [19] or for respiratory disease complex [20]. In the 
case of sheep scab, it has been shown that diagnosis and management of the disease 
could be further enhanced by combining a specific antibody test with serum biomarker 
detection for current disease status [21]. 
This technique also offers the possibility of having built-in information, without the 
need for changes to the original design. A custom-made device could be built, where 
specific information (e.g. farm holding number or disease to be tested) are added, upon 
request, to the basic platform. This could minimize the end-user input (information the 
operator is manually adding) or the operator error (no need for hand writing of 
information). 
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Correct assembly techniques can sometimes be an issue with paper-based devices [22]. 
In this case, the concept of microfluidics, which is based on interconnecting 
microchannels [23], has been exploited for easy and rapid device assembly, minimising 
inter-batch differences and reducing wastage. Because of the precise assembly, the 
spatial distances between the circular pads were kept as per a standard 96-well 
microplate, which allowed for laboratory instruments, like multichannel pipettes and 
washing manifolds, to be used with this platform, minimising the operator hands-on 
time. The precision developed in severing the interconnecting microchannels, also 
allowed for the same principle to be applied to the modified device, where the spaces 
between paper pads was further reduced and a more complicated structure was 
introduced. 
Although the technology is, at the moment, suitable specifically for laboratory 
prototyping, future high-throughput industrial manufacturing could be envisaged. A 
digital laser cutter and laminating machine, like those used in the label making industry, 
could be employed. Combining the two fabrication processes in a single machine would 
decrease the total time of production, as well as the manual operations to a minimum 
(i.e. starting of the machine and uploading of materials). More devices per sheets could 
also be produce by using bigger size sheets (i.e. from A4 to A0). Finally, the possibility 
of peeling off the devices, as demonstrated here, would also make them ready to be used 
by the final operator as they come out of the production line. 
Something that would be interesting to pursue further, is the possibility of using 
different types of paper, or even material, on the same device. In this case, an MP3 with 
three different pore size papers was fabricated, which could allow for optimisation of 
reagent deposition (e.g. the lowest possible concentration) and reaction/incubation time 
(e.g. the fastest reaction time), while maintaining analytical properties. Although no 
further testing of the other two grades of paper (WHT 4 and WHT 597) was carried out 
with immunological assays, there was a significant difference in the light transmission. 
This result is likely related to the intrinsic characteristic of the paper (specifically pore 
size and thickness) and has the potential to affect the specific requirements of an assay, 
like concentration of reagents and procedures for washing. Referring to the possibility 
of multiplexing, it would also be possible to integrate different immunoassays, which 
Chapter 3– Development of a multi-pad paper plate (MP3) for P-ELISA 
66 
might require specific substrates (i.e. nitrocellulose), on the same device. The type of 
paper used in paper-based devices has usually been chosen mainly based on fabrication 
techniques. For example, standard grade filter paper is compatible with most patterning 
techniques, while larger pore sizes (e.g. 20-25µm) are usually needed for techniques 
that requires full penetration of the cellulose fibres (e.g. ink jet printing) [24]. Using the 
technique described here, any pore size paper can be used, leaving the choice entirely 
based on the performance of the assay. Furthermore, the MP3 could be used as a 
platform to directly compare assays run on different types of papers/materials, since 
they could be performed on one device, avoiding the use of multiple devices [25] and 
possibly inter-assay differences. 
3.7 Conclusions 
In conclusion, the MP3 developed here is a valid alternative to other platforms used to 
perform P-ELISA previously described in literature. The new method of production is 
simple, rapid and of high-resolution and can produce robust, versatile and low-cost 
devices, providing 96 completely independent paper pads and compatible with standard 
laboratory microplates and instruments. It also has specific advantages in relation to this 
project and offers a platform for rapid optimisation of assay conditions. Therefore, it 
could potentially be used to transfer any type of existing ELISA into P-ELISA and 
become a diagnostic platform for detection of other disease. Although it cannot be 
considered a POC device, this fabrication technique can be applied toward the 
production of a 3D µPAD, in order to enable true POC testing at the “animal-side”. 
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Chapter 4 – Translation and optimisation of a lab-based sandwich 
haptoglobin ELISA onto P-ELISA 
4.1 Introduction 
The use of biomarkers, such as acute phase proteins, has been shown to provide 
significant aid for disease diagnosis in veterinary medicine [1]. Specifically, in the case 
of sheep scab, there is evidence that two acute phase proteins, Hp and SAA, could 
provide valuable additional information in regards of the status of the disease (active vs 
resolved) [2]. In case of a sheep scab outbreak, veterinary surgeons in Scotland need to 
certify that animals are no longer infested and/or contagious for the animal movement 
restriction to be lifted6. Using these biomarkers, coupled with a specific diagnostic test 
for sheep scab, could ensure that the correct treatment of the flock is followed and also 
establish the absence of an active infestation [2]. At the moment, the lack of low-cost 
and rapid assays to determine the concentration of either Hp or SAA in serum has 
hindered the potential of this diagnostic tool. 
Recently, a sandwich lab-based Hp ELISA protocol has been developed by Pr. David 
Eckersall (University of Glasgow). The protocol had previously been validated on sheep 
and cattle serum and used within the group for research purposes only. 
The aim of this chapter was therefore to translate the lab-based ELISA for the 
determination of Hp in serum into a P-ELISA, using the previously developed MP3 
(Chapter 3). The research question to address was the possibility of performing the 
same assay on a paper substrate, looking specifically at a reduction in the time and cost 
involved, while providing a reliable assay with analytical performances comparable to 
the conventional lab-based technique. The main expected challenges where related to 
the optimisation of the assay, in order to obtain the best possible signal with the 
minimum volume and concentration of reagents, a suitable timing for the 
immunoreactions and a functional washing technique. If successful, this would establish 
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the proof of concept that this immunoassay could be applied onto a different solid phase 
(paper instead of plastic) and the optimisation process would be applicable for 
translation of other existing lab-based ELISA onto P-ELISA. 
4.2 Optimisation of the sandwich Hp P-ELISA 
The protocol of the lab-based sandwich Hp ELISA can be found in Appendix A 
(Chapter 8) and a diagram of the assay is explained in Figure 28. All reagents 
mentioned in here, unless otherwise stated, have been sourced and prepared as reported 
in the protocol. Due to the nature of the P-ELISA assay, a different substrate solution 
(suitable for membranes) was sourced. In this case, a ready-to-use buffered alkaline 
phosphatase substrate solution, BCIP®/NBT Blue Liquid Substrate System for 
Membranes (Sigma-Aldrich, UK: Catalogue No B3804) was used. 
 
Figure 28- Diagram of the Hp ELISA. A) Deposition of capture antibody (rabbit anti-bovine IgG). B) 
Blocking to prevent unspecific binding. C) Deposition of samples containing Hp. D) Deposition of 
conjugate antibody (conjugated rabbit anti-bovine IgG). E) Deposition of substrate. F) Recording of 
the assay results. 
To translate the lab-based protocol to a P-ELISA, a number of assay conditions had to 
be optimised. These included: optimisation of washing conditions, titration of reagents, 
selection of the optimal buffers and optimisation of reaction times. 
4.2.1 Washing of the MP3 
A significant challenge in the development of the P-ELISA, was the optimisation of the 
washing technique for the MP3. Conventionally in P-ELISA, washing is done by adding 
                                                                                                                                               
6 http://www.legislation.gov.uk/ssi/2010/419/pdfs/ssi_20100419_en.pdf 
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wash buffer to the top of the platform while pressing the bottom to a piece of absorbing 
paper [3-5]. Based on initial experiments, carried out on the simplified design (Section 
3.2.1), this technique produced variable results (Figure 29), resulted in spillage of fluid 
on the bench top and proved difficult to control the exact time each pad within the 
device would be in contact with the wash buffer (variable time between paper pads for 
the wash buffer to fully cross the device into the absorbing paper). 
 
Figure 29 - Conventional washing technique for P-ELISA (3 replicates). Deposition of 2µl of WB 
(N=negative control), 32µg/ml Hp (32), 16µg/ml Hp (16), 4µg/ml Hp (4) and 1µg/ml Hp (1). After 
drying at RT for 10 min, 2µl of conjugate diluted 1:500 were deposited onto the device. After 
60seconds, 20µl WB were dispensed onto each pad and the device was placed onto a sheet of absorbing 
paper. When all the WB had been absorbed from the device to the absorbing paper, 4µl of substrate 
solution were added onto each pad and the device was scanned after 10 min. Non-specific binding can 
be observed in the negative controls and was present in the second and third replicates. 
It was also assumed that when moving from the initial design (5 paper pads) to the MP3, 
proper alignment of a multichannel pipette on top of the paper pads would require 
careful positioning and therefore extended timing for washing. A more controlled and 
effective washing technique was therefore deemed necessary. A different approach, 
which had not been applied for P-ELISA before, was based on the use of an apparatus 
for automatic washing [6]. 
Since the MP3 was designed to maintain the proportions of a standard 96-well 
microplate, a commonly used 96-well plate vacuum manifold (Bethesda Research 
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Laboratories, UK) connected to a vacuum pump (Millipore Chemical Duty 
Vacuum/pressure Pump, 115 V/60 Hz, UK) was used for plate washing (Figure 25). 
The MP3 was placed within the manifold with paper pads aligned with the sample 
application plate and the manifold was sealed with the use of thumb screws. This 
resulted in improved control of assay conditions, i.e. application of the same amount of 
washing buffer for each paper pad and the uniform exposure of the solid phase to the 
buffer. It was also considered to be a more efficient technique (average of 1 minute for 
20µl of WB to completely absorb from the MP3 into a piece of absorbing paper vs 15s 
for the vacuum to clear 100µl of WB), with prevention of liquid spillage onto the bench 
top, as waste liquid was contained in the base of the manifold for later, safe disposal. A 
set of experiments, based on the analysis of the background signal after conjugate 
antibody was deposited and washing was applied, were performed to optimise the 
specific conditions of this technique. Based on the results, the technique with the lowest 
background signal was chosen: the MP3 was placed in the vacuum manifold, with an 
absorbent pad made from Whatman Grade 1 cellulose chromatography paper placed 
underneath the MP3. After filling all the wells of the manifold with 100µl WB, the 
vacuum (set at -10Pa) was activated and remained on until all WB was cleared from the 
wells (average 15s). This procedure was repeated three times. 
4.2.2 Direct Hp P-ELISA 
Initially, a direct ELISA (Figure 30) was performed to assess conjugate antibody 
titrations and incubation, as well as different formulations of blocking buffer. Based on 
the literature, the simplest and yet effective method of reagents immobilisation on P-
ELISA is by physical absorption, by applying the solution onto the paper and allowing 
it to dry at room temperature [3, 5, 7-9]. Visual assessment of the MP3 showed that 
within 10 minutes of reagent deposition, all the paper pads were dry, therefore this was 
chosen as the binding time for Hp to the MP3. 
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Figure 30 - Schematic of the direct Hp P-ELISA. A) Deposition of 2µl Hp onto each paper pad. B) 
After 10 min at RT, 2µl blocking buffer were deposited. C) After 10 min at RT, the MP3 was placed into 
the vacuum manifold and 4µl conjugate antibody were deposited. Washing was performed as reported 
in Section 4.2.1. After washing, the MP3 was removed from the manifold and 4µl substrate were added. 
E) After 10 min at RT, the MP3 was scanned. All reagents were deposited using a multichannel pipette.  
Conjugate antibody titrations were evaluated against a range of Hp dilutions and, based 
on similar results obtained at concentration of 1:500 and 1:1000, an optimum dilution of 
1:750 was selected (Figure 31). 
   
Figure 31 - Conjugate antibody titrations. Using the protocol described in Figure 2, Hp was diluted 
1:10 (93µg/ml) in WB, then double diluted to 1:10240 (91ng/ml). A volume of 2µl of each dilution was 
applied to each column of the MP3 and the last column was left as negative control (0=WB). Conjugate 
antibody was diluted 1:50 in WB then double diluted to 1:50.000 and 4µl were applied to each row of 
the MP3 and the last row was left as negative control (WB). Washing was applied after a 60s 
incubation time. The graph shows the pixel intensity of each conjugate dilution against the Hp 
dilutions. 
The incubation time of the conjugate antibody to the antigen was also evaluated. This 
stage is critical, as leaving the reagent for too long could increase the background noise, 
but not leaving it long enough would reduce the sensitivity and the limit of detection of 
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the assay. The experiments were based on the available literature and incubation time 
ranged from 60s [3, 10] to 150s [11]. For this assay, the optimal incubation time was 
determined as 90s (Figure 32). 
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Figure 32 - Conjugate antibody incubation time. Using the protocol described in Figure 2, Hp was 
diluted 1:40 (23.25µg/ml) in WB, then double diluted to 1:640 (1.45µg/ml) and 2µl applied to each row 
of the MP3 and the last row was left as negative control (WB). Conjugate antibody was diluted 1:750 in 
WB and 4µl were applied to each column of the MP3. Washing was activated 30s, 60s, 90s and 150s 
after conjugate deposition. The graph shows the mean pixel intensity of 3 replicates and the error bars 
represent the SEM. 
As with lab-based ELISA, blocking of the paper was necessary to avoid non-specific 
binding. The most commonly used blocking buffer for P-ELISA is bovine serum 
albumin (BSA) [3] and casein [12], while the sandwich Hp ELISA in the conventional 
format uses a 10% milk protein blocking buffer (Chapter 8). Different formulations of 
blocking buffers were assessed by comparing binding of conjugate antibody to the 
paper with or without blocking buffers. Based on the results it was confirmed that the 
blocking buffer used in the conventional format was the most suitable (Figure 33). 
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Figure 33 - Selection of the blocking buffer. Each column of the MP3 was blocked using different 
formulations of blocking buffers: milk 10 (10% Marvel milk protein in WB), milk 5 (5% Marvel milk 
protein in WB), BSA 1 (1% BSA in WB), fish 5 (5% fish gelatin in WB), fish 0.5 (0.5% fish gelatin in 
WB) and negative control (WB). After 10 min at RT, the MP3 was placed into the vacuum manifold and 
4µl conjugate antibody diluted 1:750 were deposited. Washing was performed after 90s as reported in 
Section 4.2.1. After washing, 4µl substrate were added. After 10 min at RT, the MP3 was scanned. The 
graph shows the box plots of 16 replicates for each buffer. 
4.2.3 Dilution and immobilisation of the capture antibody 
Once the conditions for the direct ELISA were optimised, the final step of optimising 
the dilution and immobilization of the capture antibody was evaluated. Initially, the 
same coating buffer used in the conventional assay was used for dilution (3 replicates), 
showing no visible difference in the colorimetric reaction when serial dilutions of 
antibody titrations were evaluated against a range of Hp dilutions (Figure 34). 
 
Figure 34 - Capture antibody dilution. Serial dilutions of capture antibody in coating buffer where 
dispensed onto the MP3. Rows A to H serial dilution of capture antibody: A=1:50 (24µg/ml) to 
H=1:100.000 (12ng/ml). Column 2 to 12 double dilution of Hp in WB (2=93µg/ml to 12=91ng/ml) and 
1 negative control (WB). No colorimetric difference could be observed between the serial dilutions of 
capture antibody or the double dilutions of Hp. 
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Since conjugate and capture antibody are both purified rabbit anti-bovine haptoglobin, 
the same buffer (WB) used for dilution of the conjugate antibody was used to dilute the 
capture antibody. In this case, there was a visible difference in colorimetric reaction 
when different dilutions of Hp where evaluated. From these experiments, it was also 
possible to assess the optimal dilution of capture antibody, to achieved the best signal at 
the lowest possible antibody concentration. The optimal concentration chosen was 
1:1000 (Figure 35). 
 
Figure 35 - Capture antibody titration. Capture antibody was diluted 1:50 then double diluted to 
1:50.000. A volume of 2µl was applied to the paper pads sequentially in each row (A to G, row H was 
left as negative control=WB). After 10 min at RT, paper pads were blocked using 2µl of blocking buffer 
(10% milk protein) and allow to dry at RT for 10 min. Hp was diluted 1:10 (1=93µg/ml) in WB, then 
double diluted to 1:10240 (11=91ng/ml) and the last column was left as negative control (0=WB), 2µl 
of each dilution were applied to each column of the MP3 and the last column was left as negative 
control (WB). After 10 min at RT, the MP3 was washed as reported in Section 4.2.1. The conjugate 
antibody was diluted 1:750 in WB and 4µl were applied to each paper pad. Washing was applied after 
90s incubation time and 4µl of substrate were added. After 10 min at RT, the MP3 was scanned. The 
graph shows the mean pixel intensity (3 replicates) of each capture antibody dilutions against the Hp 
dilutions and error bars represent the SEM. 
Finally, the coating timing was tested. As reported before, binding of reagents to the 
paper in P-ELISA is usually achieved by physical absorption and this was assumed by 
experiments done with the conjugate antibody, where despite vigorous washing, signal 
was still visible (Figure 36).  
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Figure 36 - Particular of an MP3 showing conjugate antibody binding to the paper pads. A volume of 
2µl of serial dilutions of conjugate antibody (1:50 to 1:5000) was applied sequentially to each row (6 
replicates). After drying at RT for 10 min, the device was washed as reported in Section 4.2.1 and 4µl 
of substrate were added. After 10 min at RT, the MP3 was scanned. 
Therefore, the solution of capture antibody was deposited in the centre of the pad with a 
multichannel pipette. Since drying time for the MP3 was visually assessed as complete 
by 10 minutes, a minimum time of 10 minutes at room temperature between deposition 
of the capture antibody and the following step in the assay was chosen. 
4.2.4 Optimised sandwich Hp P-ELISA 
Based on the results obtained, the optimised protocol for the sandwich Hp P-ELISA 
applied to the MP3 was as follows: purified rabbit anti-bovine haptoglobin IgG was 
diluted to 1:1000 in WB. A volume of 2µL of the prepared solution was deposited onto 
each pad and the paper was allowed to dry at RT for 10 minutes. Non-specific binding 
was limited by the addition of 2μl of blocking buffer (10% milk protein) followed by 
drying at RT for 10 minutes. Standard bovine haptoglobin was diluted 1:5 in WB and 
then double diluted; 2µL of neat Hp solution and of each dilution were deposited onto 
the pads (sequentially in each column) and allowed to react for 10 minutes at RT. The 
device was washed with 100µl WB as described in Section 4.2.1. The purified rabbit 
anti-bovine haptoglobin IgG was conjugated with alkaline phosphatase (Chapter 8) then 
diluted 1:750 in WB. A volume of 4µl was then deposited onto each pad of the MP3 and 
incubated at RT for 90 seconds. The device was washed again. A volume of 4µl of 
ready-to-use buffered alkaline phosphatase substrate solution was added to each pad. 
After 10 minutes at RT, the MP3 was scanned using a desktop scanner. 
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4.3 Standard curve for the sandwich Hp P-ELISA 
Using the MP3 and the optimised sandwich Hp P-ELISA, it was possible to demonstrate 
that increasing concentrations of bovine standard Hp resulted in increasing intensity 
responses, based on a colorimetric reaction and visible with the naked eye (Figure 37).  
 
Figure 37 - Sandwich Hp P-ELISA on the MP3. The protocol used is as reported in Section 4.2.4. 
Column 1 to 11 double dilution of Hp (1=0.93mg/ml to 11= 0.36µg/ml) and 12 negative control (WB). 
Rows A to H replicates (n=8).Some degree of unspecific binding can be seen in pads C, D, G and H 12. 
Average pixel intensity values for each circular pad were analysed and correlated with 
the different concentrations of Hp. A standard curve was generated using non-linear 
regression and a sigmoid curve response (variable slope) was obtained (Figure 38), 
showing high correlation between pixel intensity and Hp concentration (R2 = 0.85). The 
limit of detection (LOD) achieved was 1.7µg/ml, calculated as the mean of the negative 
control sample plus three times the standard deviation of the negative control sample 
and plateau of the signal intensity was found at an Hp concentration of 23.25µg/ml. 
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Figure 38 - Non-linear regression (variable slope) of mean pixel intensity in relation to Hp 
concentration (µg/ml). Each data point represents the mean of 8 replicates. Error bars represent 
standard deviations. 
4.4 Cost-benefit analysis of lab-based vs MP3 sandwich Hp P-ELISA 
The total time required to perform a complete P-ELISA on the MP3 was 40 minutes and 
multiple devices (up to 3) could be processed at the same time. The time and cost for 
performing the sandwich Hp P-ELISA assay on the MP3 was considerably reduced 
when compared to the same assay performed in the conventional lab-based ELISA 
format, where reductions of 88% in cost and 93% in time were achieved (Table 1). A 
cost/sample of 0.13 pence (when samples are run in duplicates in each device) was 
calculated versus a £1/sample for the lab-based ELISA. 
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Table 1 - Cost-benefit analysis of performing the sandwich Hp ELISA on the MP3 or with the lab-
based technique. # negligible cost. 
  Hp P-ELISA on the MP3  Lab-based Hp ELISA  
  
Volume 
(µL) 
Time 
(min) 
Cost 
per 
plate 
Volume (µL) 
Time 
(min) 
Cost per 
plate 
Capture antibody 2 10 £1 100 480 £5.5 
Blocking buffer  2 10 # 200 60 # 
Antigen (Hp) 2 10 £1.2 100 60 £15 
Conjugate antibody  4 1.5 £3.4 100 60 £20 
Substrate  4 10 £0.4 100 10 £10.5 
Plate - - £0.3 - - £1.5 
Total  14 41.5 £6.3 600 670 £52.5 
4.5 Discussion 
This chapter describes the successful translation of a sandwich ELISA for the 
determination of Hp in serum from the lab-based format onto P-ELISA. The use of the 
previously developed MP3 was crucial for the optimisation of the assay conditions, 
allowing for the different variables to be tested with a systematic and standardized 
approach. 
Within the optimisation process, an important contribution to the washing technique 
was made. To date, all P-ELISA applied to these type of devices (96-pad devices made 
of paper), are washed by depositing wash buffer and using a paper towel to absorb it 
through [3-5, 7-9, 11, 13]. Although all these studies report successful P-ELISAs, there 
is a lack of repeatability and also reduced control over the washing conditions. Using 
this technique in the initial experiments, it was noted how unpredictable was the timing 
for the washing buffer to completely adsorb through the device. This resulted in 
increased variability within the colorimetric reaction. An alternative approach was 
therefore explored to standardize the washing condition, which resulted in a constant 
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amount of washing buffer going through all the paper pads for the same amount of time. 
Furthermore, there could also be issues with health and safety associated with reagents 
and biological samples used within the assay and transferred onto the absorbing paper 
that would be manually handled by the operator. Potentially toxic reagents might be 
used or personnel could have specific allergies to certain products (i.e. milk proteins). In 
this case, spillage or handling of the impregnated absorbing towels could represent an 
additional constrain for the operator as well as for disposal. One reason why a vacuum 
manifold has not been used before could be related to the fabrication technique of these 
devices, which might not provide sufficient strength to withstand the vacuum pressure. 
On the contrary, the MP3 has shown to be a robust device that can support strong 
pressure (up to -50Pa) without tearing of the paper pads. A similar approach has already 
been taken for a nitrocellulose based assay [14] which also employs a 96-well vacuum 
manifold. In this case, the whole nitrocellulose membrane is spotted with capture 
reagents, in a pattern to recreate a standard 96-well plate format. Using the MP3, it was 
possible to apply controlled and vigorous washing on a low-cost substrate (£0.3/MP3 vs 
approximately £2/nitrocellulose membrane), while maintaining the ease of fabrication 
(pipettes for physical absorption of capture reagents vs expensive reagent spotting 
systems). A possible criticism of this alternative washing technique, is the need for an 
increased amount of washing buffer. Generally, between 10 [3] to 20µl [11] of wash 
buffer are used, while an optimum amount of 100µl was estimated for the alternative 
washing technique. Although a significant increase in the amount of wash buffer is 
necessary, the cost of these buffers is usually negligible in comparison to the other 
reagents and would not considerably affect the overall cost when applied to P-ELISA. 
Even though a different solid phase was used, most of the assay conditions were kept as 
per the conventional assay. The main differences were in the substrate, which was 
selected to be specific for membranes and also in the coating buffer used. Most of the P-
ELISAs use phosphate-buffered saline (0.01M PBS, pH 7.4) [3, 11, 13, 15] or double 
distilled water [5, 8] as diluting buffers for the coating stage, while the one used in the 
conventional format (0.05M NaHCO3 pH 9.6) is a commonly used coating buffer for 
lab-based ELISA[16]. The same WB was also used in the Hp P-ELISA for diluting all 
the reagents and for washing, which has simplified furthermore the P-ELISA compare 
to the lab-based format. In both cases, binding of proteins to the solid phase is achieved 
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by physical/passive absorption. In the case of the lab-based ELISA, this is due to 
hydrophobic interactions, which require higher pH than the isoelectric point of the 
protein to be attached, as well as long incubation times and specific temperature 
selection [17]. For the paper substrate, the interaction is based on dispersion and 
electrostatic forces, which makes the pH less important and therefore the type of buffer 
not so critical. Most P-ELISA rely on the simple method of binding, with a common 
incubation time of 10 minutes [3, 5, 9, 15], which is the average time for drying of these 
devices at room temperature. Although physical immobilisation on paper is not consider 
the most robust strategy [18], in this case it was still effective, despite application of 
vigorous washing (Figure 36). The possibility of using modified paper, by chitosan 
coating and glutaraldehyde cross-linking [11], to increase the binding capacity could be 
something worth exploring when translating the P-ELISA into a 3D µPAD format, 
where the presence of vertical and lateral flow might require a stronger immobilisation 
method or possibly a longer incubation period. 
Although all conditions had been thoroughly investigated to optimise the assay, some 
degree of unspecific binding was still noted (Figure 37), which explains the LOD being 
higher than the one reported for the conventional lab-based ELISA. Through further 
optimisation or by considering alternative detection methods, the background noise 
could be reduced, with increase sensitivity of the assay. At this stage, however, this was 
not deemed necessary, given the clinically high concentration of circulating Hp and the 
rationale behind these experiments, which were aimed at translating the assay on the 
paper substrate. 
Finally, although still requiring specific laboratory instruments (a vacuum manifold and 
pipettes) and non-portable equipment (a desktop scanner), this assay could potentially 
be carried out “in house” (i.e. within veterinary clinics) due to the considerably 
reduction in cost and time. Based on the standard curve generated, the recommended 
serum dilution could be 100-fold. Ovine serum presents a physiological range of 0.3-
1.57 mg/ml for currently non-infested animals [2], which, at the proposed dilution, 
would be either below the LOD or within the detectable range of dilutions. The post-
infestation rise to 3.53mg/ml [2], would be above the signal plateau and therefore would 
be considered a positive result. The total assay time was below 45 minutes for the P-
Chapter 4– Translation and optimisation of a lab-based sandwich haptoglobin ELISA onto P-ELISA 
84 
ELISA, compared to approximately 11 hours for the lab-based ELISA. The major factor 
in this considerable time reduction was the absence of the overnight coating incubation. 
Although this does not require much hands-on time, it requires planning of the 
diagnostic tests to be carried out. In the case of a disease outbreak, such as for sheep 
scab, it is not possible to forecast when the disease will occur and therefore it would be 
desirable to have a test that can be rapidly deployed on the same day and possibly 
within few hours. 
4.6 Conclusions 
The experiments carried out in this chapter demonstrated that the Hp assay for the 
diagnosis of sheep scab can be applied onto a new substrate (paper), showing direct 
correlation between the colorimetric signal and the concentration of Hp. The time and 
cost for performing this assay on paper are considerably reduced and, while the 
analytical performances are still below the conventional lab-based ELISA, the 
correlation of the signal with the diagnostic ranges of Hp concentration is sufficient for 
the tests to be used in clinically relevant situations. Furthermore, the use of the MP3 
provided a significant advantage in the translation and optimisation of the sandwich Hp 
P-ELISA and will form the basis for the final POC device. It also contributed to the 
available literature by providing improvements to the existing P-ELISA techniques, 
specifically by developing a more standardized and controlled washing technique for 
these devices. 
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Chapter 5 – Diagnosis of sheep scab by Pso o 2 indirect P-ELISA on 
the MP3 
5.1 Introduction 
The recent development of a lab-based indirect ELISA for the detection of antibodies 
specific to a mite allergen (Pso o 2) has proven a highly sensitive diagnostic test for 
both clinical and sub-clinical sheep scab [1, 2]. The test can be very valuable during a 
sheep scab outbreak, where the main purpose is the exclusion of other common diseases 
causing similar clinical signs (e.g. pruritus and wool loss), like other ectoparasites [3], 
photosensitization [4] or scrapie [5]. In this case, all the animals showing clinical signs 
of the disease or a proportion of the affected ones can be sampled. Although skin 
scraping is still considered the routine technique for clinically evident sheep scab, it is 
relatively time consuming and requires a skilled operator for microscopic identification 
of ectoparasites [6]. A serological assay could be more appropriate when dealing with 
diseases at a flock rather than individual level [7]. 
The lab-based ELISA can also reliably diagnose sheep scab as early as 2 weeks post-
infestation, where at least half (6/11) of the animals showed elevated serum IgG 
responses, while detection of mites using skin scraping would only achieve below 20% 
rate (2/11 animals) [8]. The test has also been shown to detect pre-clinical infestation 
during a natural outbreak of sheep scab [2]. The test could therefore represent a very 
valuable screening tool when animals are quarantined after being bought in, returning 
from away wintering or rented to other farms for mating. 
The main problems, in both these situation, are the time from sample collection to result 
acquisition and the cost of the test. Although commercially available, this test is run by 
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a laboratory once a week for a cost of £9.50/sample7 and a minimum of 12 animals 
should be sampled per flock.  
In the case of an outbreak, the farmer would either have to wait potentially for a whole 
week (during which animals could infect neighbouring premises and the farm will be 
under movement restriction) or might decide to treat before having received the results. 
Furthermore, due to the antiparasitic drugs being relatively low-cost, the expenses of 
blank treatments would likely be cheaper than the overall cost of testing (including 
labour cost for gathering animals twice) [9]. It is obvious that having this assay as a 
low-cost POC test would further improve the diagnosis and appropriate usage of anti-
parasitic drugs for sheep scab [10]. The same applies in case of quarantine treatments, 
where it might encourage farmers to screen all or a proportion of incoming animals, to 
prevent the disease from entering the flock. 
The research question to address was the possibility of performing the other assay for 
the diagnosis of sheep scab on a paper substrate, specifically by looking at 
differentiation between infested and non-infested animals. The main foreseen challenges 
where related to the absence of standards for reference and the need to use serum 
samples. The aim of this chapter was therefore to translate the existing indirect Pso o 2 
ELISA from its lab-based format onto P-ELISA, using the previously developed MP3 
and, once optimised, serum samples from naïve or scab infested sheep would be 
analysed and results compared with the lab-based ELISA.  
5.2 Optimisation of the indirect Pso o 2 P-ELISA 
A similar approach to the techniques explained in Chapter 4 was applied for the 
translation of this assay into a P-ELISA. The protocol of the indirect lab-based Pso o 2 
ELISA can be found in Appendix B (Chapter 9) and a diagram of the assay is explained 
in Figure 39.  
                                                 
7 http://www.biobest.co.uk/assets/files/news/Sheep-scab-ELISA-Test-Press-Release.pdf 
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Figure 39- Diagram of the Pso o 2 ELISA. A) Deposition of capture antigen (Pso o 2). B) Blocking to 
prevent unspecific binding. C) Deposition of serum samples containing IgG. D) Deposition of 
conjugate antibody (conjugated rabbit anti-ovine IgG). E) Deposition of substrate. F) Recording of the 
assay results. 
Specific parameters had to be optimised, as the working medium (serum) presents 
further challenges compared to buffer/standard solutions. The serum samples used for 
the optimisation were as reported in Section 2.2.2. All reagents mentioned in here, 
unless otherwise stated, were as reported in the protocol. Further reagents not reported 
in the protocol can be found in Section 2.3. Due to the nature of the P-ELISA assay, a 
different substrate solution (suitable for membranes) was sourced. In this case, a ready-
to-use 3,3′,5,5′-Tetramethylbenzidine (TMB) Liquid Substrate System for Membranes 
was used (Sigma-Aldrich, UK. Catalogue No T0565). 
Some of the conditions already optimised for the sandwich Hp P-ELISA (reagents 
volume, incubation timing at room temperature and washing of the MP3) were tested 
again, confirming they were also suitable for this assay, while ad-hoc experiments were 
designed to evaluate conditions specific to this assay. 
5.2.1 Titration and incubation of conjugate antibody 
Initially, experiments were performed to assess the conjugate antibody titration and 
incubation time. Sequential dilutions of the conjugate antibody were deposited onto the 
MP3 and washed after increasing incubation time. At 90s incubation time and with a 
2000-fold dilution of the conjugate antibody, the signal was still visible but 
considerably reduced and these parameters were chosen for the assay. (Figure 40). 
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Figure 40 - Conjugate antibody titrations and incubation timing. The MP3 was placed in the vacuum 
manifold and 4µl conjugate antibody, diluted sequentially from 1:100 to 1:10000 with PBST80 used as 
negative control, were deposited. Washing was performed for 30s, 60s, 90s or 120s after conjugate 
deposition. A volume of 4µl substrate solution was added and the MP3 was scanned after 10 min. The 
graph shows the mean pixel intensity of 3 replicates and the bars show the SD. 
5.2.2 Blocking buffer 
Initial experiments showed that there was a high degree of non-specific binding (Figure 
41).  
 
Figure 41 - High background noise due to non-specific binding. Coating antigen was diluted 1:10 and 
2µl were deposited on the MP3. After drying at RT for 10 min, 2µl PBST80 were spotted on each pad. 
After 10 min at RT, 2µl of positive (column 1-5) and negative (column 7-12) control serum samples 
diluted 1:50 were spotted. Column 6 and 12 were kept as control (2µl PBST80). After 10 min, the MP3 
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was washed and 4µl conjugate antibody diluted 1:2000 were added and incubated for 90s. After 
washing, 4µl substrate were added and the MP3 was scanned after 10 min. There is a high degree of 
background noise in the negative serum samples. 
Different blocking buffers were therefore assessed to reduce the degree of non-specific 
binding and background noise. Experiments showed that the optimum solution between 
the lowest background noise and a strong positive signal, was achieved using 5% (w/v) 
fish gelatine in PBSx10 (BB) (Figure 42). 
 
Figure 42 - Evaluation of blocking buffers. 2µl of coating antigen diluted 1:10 were deposited on the 
MP3. After drying at RT for 10 min, 2µl of the different blocking buffers under evaluation were spotted 
onto each pad in quadruplicate.: BSA (BSA 1%), fish gelatin (fish gelatin 5%) and PBST80. After 10 
min at RT, 2µl of positive and negative control serum samples diluted 1:50 were spotted. After 10 min, 
the MP3 was washed and 4µl conjugate antibody diluted 1:2000 were added and incubated for 90s. 
After washing, 4µl substrate were added and the MP3 was scanned after 10 min. The graph shows the 
mean pixel intensity of 8 replicates for positive (first column) and negative (second column) serum 
samples and the error bars show the SD. 
5.2.3 Checkerboard titrations 
In order to achieve the best signal possible with the minimum concentration of reagents 
and samples, optimisation of the amount of coating antigen and serum dilution for the 
P-ELISA where investigated. To do so, a checkerboard titration, where serial dilutions 
of coating antigen are tested against serial dilutions of serum (used as positive and 
negative controls) was used. 
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The most suitable coating antigen dilution was 1:2 in double distilled water, with a 
concentration of rPso o 2 of 0.26mg/ml and for the serum dilutions, the optimum 
dilution was 1:50 in PBST80 (Figure 43).  A two-way ANOVA showed there was no 
significant difference within the replicates values (column factor), but there was a 
significant difference (p=0.017) between the values obtained at different serum dilutions 
(row factor). Serum dilutions 1:50 and 1:100 where statistically significant different 
(p<0.05) when compared using Tukey’s multiple comparison test to all the other serum 
dilutions for coating antigen either neat or diluted 1:2. 
 
Figure 43 - Checkerboard titrations to evaluate coating antigen and serum dilutions. A volume of 2µl 
of coating antigen was deposited on the MP3 [neat to 1:100 and a control with double distilled water 
(dd)]. After drying at RT for 10 min, 2µl of BB were spotted onto each pad. After 10 min at RT, 2µl of 
positive (column 1-6) and negative (column 7-12) serum samples sequentially diluted (neat to 1:500 
and the last row kept as negative control, PBST80) were spotted. After 10 min, the MP3 was washed 
and 4µl conjugate antibody diluted 1:2000 were added and incubated for 90s. After washing, 4µl 
substrate were added and the MP3 was scanned after 10 min. The graph shows the difference in mean 
pixel intensity between positive and negative serum (3 replicates) and the error bars the SD. *=p<0.05. 
5.2.4 Serum incubation 
To further improve the assay by increasing the colorimetric difference between positive 
and negative samples, an extended timing for serum incubation was evaluated. Ovine 
IgG has relatively low affinity for the Pso o 2 antigen (Dr. Francesca Nunn, Personal 
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Communication), which might require longer incubation time to improve the signal 
intensity. Based on this assumption, serum incubation time was extended to 15, 20 and 
30 minutes. Results, however, showed a high degree of non-specific binding, as no 
difference was visible between positive and negative samples (Figure 44), therefore the 
serum incubation timing was kept at 10 minutes. 
 
Figure 44 - Serum incubation timings. A volume of 2µl of coating antigen diluted 1:2 in double 
distilled water was deposited on the MP3. After drying at RT for 10 min, 2µl of BB were spotted onto 
each pad. After 10 min at RT, 2µl of positive (column 1-2, 5-6 and 9-10) and negative (column 3-4, 7-8 
and 11-12) serum samples diluted 1:50 in PBST80 were spotted. After 30 min (column 1-4), 20 min 
(column 5-8) and 15 min (column 9-12), the MP3 was washed as reported in Section 4.2.1 and 4µl 
conjugate antibody diluted 1:2000 were added and incubated for 90s. After washing, 4µl substrate were 
added and the MP3 was scanned after 10 min. There is a high degree of background noise in the 
negative serum samples for all serum incubation timings tested. 
5.2.5 Read-out timing 
A reduction in the read-out timing from 10 to 5 minutes was possible with this P-ELISA 
as the development of a strong signal was readily detectable within 5 minutes of the 
addition of the substrate (Figure 45). 
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Figure 45 - Read-out timing. Indirect Pso o 2 P-ELISA carried out as per Section 5.2.6 A) The MP3 is 
scanned 5 min after addition of substrate. B) The MP3 is scanned 10 min after addition of substrate. 
5.2.6 Optimised indirect Pso o 2 P-ELISA 
Based on the results obtained, the optimised protocol for the indirect Pso o 2 P-ELISA 
applied to the MP3 was as follows: rPso o 2 was diluted to 0.26mg/ml in double distilled 
water. A volume of 2µL of the prepared solution was deposited onto each pad and the 
paper was allowed to dry at RT for 10 minutes. Non-specific binding was limited by the 
addition of 2μl of BB (fish gelatin 5%) followed by drying at RT for 10 minutes. Serum 
samples were diluted 1:50 in PBST80 and 2µL were deposited onto the pads and 
allowed to react for 10 minutes at RT. The device was washed with 100µl WB as 
described in Section 4.2.1. The rabbit anti-ovine IgG HRP conjugate was diluted 1:2000 
in PBST80 and 4µl were then deposited onto each pad of the MP3 and incubated at RT 
for 90 seconds. The device was washed again. A volume of 4µl of ready-to-use 
substrate solution was added to each pad. After 5 minutes at RT, the MP3 was scanned 
using a desktop scanner.  
5.3 High-throughput analysis of data 
During the larger scale experiments performed to optimise the two P-ELISAs, it was 
evident that the manual analysis of a considerable amount of data was extremely labour-
intense and not suitable for a possible application as a POC device. To improve upon 
the previously used protocol (Section 2.5), using Image J after the image had been 
inverted and an oval selection of the area was manually drawn to each paper pad, a 
novel solution was explored, using a purpose-written MATLAB code to automate data 
analysis. 
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5.3.1 MATLAB code 
Based on the protocol developed to analysed data on Image J, an algorithm was written 
in collaboration with Dr. Alan Faulkner-Jones and used to generate a code to be 
processed by MATLAB R2015b (The MatWorks®, Inc., US) (Chapter 10). To maintain 
the same output as the original data (analysis of mean grey pixel intensity) the algorithm 
automatically converts the image into grayscale and inverts it. The first problem 
encountered, however, was that the scanned MP3 were in different positions (rows and 
columns will be at different angles, based on the position of the MP3 within the 
scanner). To solve this problem, an algorithm was written to automatically rotate the 
picture so that rows and columns would be aligned, before the analysis took place. The 
operator manually locates a 6mm diameter circle on the first (A1) and last (H12) of the 
paper pads and double clicks each time. The algorithm automatically calculates the 
position of all the other pads within the picture and gives a mean pixel intensity value 
for all pads by generating an excel spreadsheet. 
5.3.2 Image J vs MATLAB 
A reduction from 210 to 4 (positioning of circle and double click x 2) manual steps was 
achieved using MATLAB. An average of 8.30 minutes was needed to fully analyse one 
MP3 using Image J, while an average of 1 minute was necessary to analyse the same 
data using MATLAB. Data generated from Image J and MATLAB from the analysis of 
the same MP3 were compared using Pearson correlation, showing agreement (r=0.98) 
between the two techniques (Figure 46). Data were analysed on two further MP3, 
showing similar correlation (r=0.97 and r=0.99). Based on these results, the purpose-
written MATLAB code was used for all future data analysis of this chapter. 
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Figure 46 - Correlation between pixel intensity measurements obtained using Image J or the purpose-
written MATLAB code. The graph shows the intensity of the pixel for each pad of the MP3 (n=96) used 
for the evaluation of blocking buffers (Figure 42). 
5.4 Performance of the Pso o 2 P-ELISA with ovine serum 
In order to evaluate the application of the optimised Pso o 2 ELISA (protocol reported 
in Section 5.2.6) on the MP3 in clinically relevant settings, analysis of ovine serum 
(Section 2.2) with known degree of infestation were performed.  
5.4.1 Positive vs negative serum samples 
To assess if the optimised Pso o 2 P-ELISA could differentiate between infested and 
naïve animals, a comparison of the mean pixel intensity between positive (n=6) and 
negative (n=6) control serum samples (Section 2.2.2) was performed using a Student’s 
paired t-test. Two replicate MP3 were used and samples were run as triplicates on each 
device (n=36). To analyse data from different MP3 pixel intensity values were 
normalised. The average of 4 measurements from the control pads (paper pads where no 
serum was deposited) from the same MP3 were subtracted from the pixel intensity 
values of each paper pad. 
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The mean pixel intensity for the positive samples was 37.91±1.8 (SEM) and 29.7±1.8 
(SEM) for the negative samples, with a significant difference (p=0.001) between the 
two sets of data (Figure 47). 
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Figure 47 - Box-plot of positive and negative samples. Normalised pixel intensity obtained from serum 
of positive (n=36) and negative (n=36) control serum samples. *p=0.001. 
5.4.2 Comparison of the results from the conventional lab-based ELISA and the P-
ELISA 
To assess whether the optimised Pso o 2 P-ELISA would provide comparable results to 
the conventional lab-based Pso o 2 ELISA (Chapter 9), samples were analysed with the 
two techniques and the results were compared. For the analysis, a total of 52 clinical 
samples (Section 2.2.1) were analysed using a total of 6 MP3. Serum samples were run 
in duplicates and two platforms were run on the same day, while the other 4 were run 
sequentially on a different day. To analyse data from different MP3 pixel intensity 
values were normalised. The average of 6 measurements from the control pads (paper 
pads where no serum was deposited) from the same MP3 were subtracted from the pixel 
intensity values of each paper pad. 
Samples analysed where classified as positive or negative based on the results from the 
conventional lab-based ELISA and agreement between the two tests was evaluated. 
Samples were considered positive by the MP3 if they showed a positive result (pixel 
intensity equal or higher than the positive control) from at least 2 out of 3 replicates. If 
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the lab-based ELISA is considered as the “gold standard technique”, then a sensitivity 
of 57.9% and a specificity of 87.8% were achieved by the test performed as P-ELISA 
on the MP3 (Table 2). The measurement of agreement between test was k=0.56. 
Table 2 - Comparison between samples testing positive or negative using the lab-based or the P-ELISA. 
 
Lab-based ELISA 
Positive Negative 
P-ELISA 
Positive 11 4 
Negative 8 29 
 
Pearson correlation between the OD values from the lab-based ELISA and the mean 
pixel intensity of the P-ELISA was 0.54 (95% CI 0.32-0.7). When analysed at single 
time points, significant correlation where found at week 5, r=0.83 (95% CI 0.3-0.97) 
and week 6, r=0.89 (95% CI 0.5-0.98) (Figure 48). 
 
Figure 48 - Scatter plot of the correlation between lab-based ELISA and P-ELISA. The graphs show 
the correlation between OD values obtained with the lab-based ELISA and mean pixel intensity with 
the P-ELISA for blood samples taken at week 5 and at week 6 post-infestation. 
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5.5 Discussion 
In this chapter, the translation and optimisation of a different lab-based ELISA into P-
ELISA was demonstrated. Based on the knowledge acquired during the previous set of 
experiments, this process was significantly faster. The use of the MP3 with a methodical 
approach could therefore potentially be implemented for translation of most, if not all, 
lab-based ELISA into P-ELISA. The biggest challenge, in this instance, was the absence 
of standards for optimisation of the technique and the need to use serum samples. The 
recent development of the lab-based ELISA and the availability of samples from 
experimentally infested animals were of paramount importance in this instance. 
Although, ideally, neat serum would be used at the POC, at this stage it was not suitable 
for the assay and an optimum dilution of 1:50 was chosen. Commonly, the lowest 
possible dilution would be chosen for lab-based immunological assay, in order to reduce 
sample usage to the minimum. In the case of POC tests, precise dilutions might not be 
achieved as the use of laboratory pipettes will not be available in the field. A more 
appropriate procedure could be the use of syringes or transfer pipettes where drops 
(rather than µl) of sample and buffer solution could be used for dilution. Furthermore, in 
the case of farm animals, blood samples are usually collected into 5 to 10 ml blood 
collection tubes, which means low sample volume is not usually an issue. 
An interesting finding, during the optimisation process, was the reduction in the read-
out timing compare to the previously optimised P-ELISA (5 minutes vs 10 minutes), 
with a further reduction in the overall assay timing from approximately 40 minutes to 
just over half an hour. Although at this stage, a 10 minutes serum incubation was 
deemed suitable for this assay, this might not be the case for other P-ELISA. Different 
P-ELISAs might require different timings at specific stages of the assay. If these assays 
were to be run in conjunction (e.g. multiplexing), there will be substantial advantages in 
using 3D µPADs, as the manipulation of fluid can be tailored to each assay [11]. 
A further contribution to the performance of P-ELISAs was made by the development 
of an automated procedure for image analysis, where a reduction from approximately 8 
minutes to 1 minute for the analysis of one MP3 was achieved. Most of the P-ELISA 
relying on colorimetric reactions are currently using Image J [12-14] or Photoshop® 
[15, 16] to analyse the scanned images of the devices. To date, only one study has 
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applied the use of a MATLAB code for automation of image analysis [17]. The main 
differences in the codes used are the creation of a mask to locate the paper pads within 
the image and the analysis in RGB instead of grayscale. A rapid and clear display of the 
test results for the end-user is still an area that needs further development [18]. As more 
research will hopefully be carried out on automatic image analysis, a standard code 
could be generated, which would then be tailored to suit the specific conditions. 
Finally, the optimised protocol for indirect Pso o 2 P-ELISA was also applied for 
analysis of animal samples with known degrees of sheep scab infestation. Recently, an 
increasing number of studies have assessed the clinical performance of P-ELISA on 
disease diagnosis [13, 15, 16]. The possibility of applying research findings into 
practical applications is the mainstem of all interdisciplinary research and represent the 
final aim of this research project. The encouraging performances of the Pso o 2 P-
ELISA in differentiating between positive (infested) and negative (naïve animals) could 
be used in clinical settings where an animal is showing clinical signs of the disease (i.e. 
pruritus and wool loss) as an alternative to the skin scraping method and as a rapid test 
compare to the conventional lab-based ELISA. In this case, all animals showing clinical 
signs would be sampled at the veterinary practice, as it is routinely done for skin 
scrapings, with results available within limited time (i.e. just over half an hour) and 
reliable results. This will allow for confirmation of the disease and targeted treatment to 
be applied for each animal. There was also a good correlation of the Pso o 2 P-ELISA 
with the conventional lab-based ELISA results, for samples at 6 weeks post-infestation. 
These results would allow for the P-ELISA to be used for field diagnosis of clinical 
sheep scab within the flock, as animals naturally infested will have been in contact with 
the parasite at different times, but they tend to show clinical signs from 8 weeks post-
infestation [19] and are therefore likely to give a positive result at the test. In this case, 
as it is recommended for the conventional lab-based ELISA, a minimum of 12 animals 
per flock should be sampled to provide reliable results. When samples were compared at 
2 weeks post-infestation, which is the earliest detection of sub-clinical infestation using 
the lab-based ELISA, correlation was low (results not shown). This was likely due to 
the lower sensitivity of the P-ELISA compared to the lab-based assay, and something 
that would need further consideration. A possible explanation for these results could be 
the level of background noise. Although there was a significant difference in signal 
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between positive and negative samples, mean intensity of the negative samples was 
around 29 pixels (Figure 47). Similar high background noise was also noticed for an 
indirect P-ELISA for the diagnosis of leishmaniosis in dogs [13], where they 
demonstrated a significant difference between positive and negative samples, but the 
mean intensity of the negative (non-infected animals) samples was high. The high 
degree of background noise was already noticed in the initial experiments, where a 
different blocking buffer was necessary to decrease the rate of non-specific binding. 
This problem was not encountered, for example, when the sandwich Hp P-ELISA was 
developed (mean intensity of the negative control of approximately 12 pixel). In the 
case of the Pso o 2 assay, however, a horseradish peroxidase (HRP) conjugate antibody 
was used, which has been reported to develop high colorimetric intensity in negative 
samples [20]. The lower analytical sensitivity is possibly one of the main criticisms 
toward paper-based immunoassay, especially where a colorimetric reaction is used [21]. 
Different solutions have been proposed to address this problem, like the use of 
polymerisation-based colorimetric methods [14] or the use of nanoparticle labels [22]. If 
a better sensitivity could be achieved, a useful application of this P-ELISA would be 
either the regular screening of flocks for early detection (e.g. sub-clinical) of diseases 
animals or sampling of incoming animals to prevent introduction of the disease into the 
flock. 
5.6 Conclusions 
In this chapter, the indirect Pso o 2 ELISA was successfully translated onto P-ELISA 
and used to analyse serum samples to detect specific antibodies against sheep scab. The 
differentiation between positive and negative samples would allow for the rapid test 
performed on the MP3 to be used in clinical settings (i.e. a veterinary practice). The 
experiments performed have deepened the knowledge of some of the fundamental 
mechanisms involved in the interaction between biological substances and the paper 
substrate. In specific, the use of serum samples has highlighted the difficulties in 
preventing non-specific immunoglobulin (i.e. IgG) to bind to the paper, which has 
resulted in higher background noise than by using buffer solutions. It also allowed 
further improvement in the analysis of data, with a considerable reduction in time, a 
more user-friendly protocol and automated analysis of data. 
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Chapter 6 – Development of a microfluidic paper-based analytical 
device (µPAD) for point-of-care animal disease testing 
6.1 Introduction 
The opportunities offered by the application of microfluidic paper-based analytical 
devices (µPADs) for disease testing are incredible, meaning that testing can truly be 
done at the point-of-care (POC) and for a fraction of the cost of existing assay systems 
[1]. In the field of human medicine these devices are receiving increasing attention, the 
same, however, cannot be said for veterinary medicine. At present, studies on POC 
testing for animal diseases are still focused on the use of either dipstick [2-4] or lateral 
flow devices [5, 6], with very positive results, but also with the intrinsic drawbacks of 
these platforms. 
Although in principle, fabrication techniques and detection methods would be the same, 
there is a clear need to show that these devices can also be applied for diagnosis of 
animal diseases. Making researchers and end-users aware of the advantages and of the 
possible applications offered by these new technologies is the first step in this direction 
[7]. At present, however, emphasis is often placed on achieving complicated 3D 
structures with impressive fluid flowing capabilities [8], while what is actually needed, 
especially in farm animal diagnostics, is a simple yet effective and low-cost solution to 
diagnose disease, which can be easily translated to the field. 
The aim of this chapter was, therefore, the development of a µPAD suitable for point-
of-care testing of animal diseases. Initially, a 2D device was developed in order to 
establish fluid flow dynamics and reaction timings. To evaluate the device an 
immunoassay, a direct Hp P-ELISA, was used as a model assay. Based on these results, 
a 3D µPAD was fabricated, which would allow for the manual steps done by the 
operator to be reduced (increase automation) and for multiplexing, with the final aim of 
having both diagnostic tests for sheep scab on a single device. The device was then 
tested with the same direct Hp ELISA, to show its functionality for application with 
biological assays. The main challenges foreseen where the suitable timings for 
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immunoreactions to occur in relation to the physics of the fluid flow, addressed with the 
2D device, and the combination of vertical and horizontal fluid flow, as well as suitable 
packaging/assembly of the 3D device in order to obtain a constant fluid flow with no 
spillage in between layers and a working immunoassay. 
6.2 Two-dimensional microfluidic paper-based analytical device (2D µPAD) 
design and fabrication 
The designs for the 2D µPAD were based on the extensive literature available from the 
early paper-based devices [9-11]. In the development of a POC test, an ideal 
compromise between the fastest result possible and the timing of the immunological 
reactions is crucial. If the necessary time for reagents to react is not allowed, the 
analytical properties might be significantly affected [12]. This preliminary work was 
therefore fundamental to understand the physical properties (the length and the width of 
the channels and the effect of lamination), which can affect the flow rate and therefore 
the outcome of the immunological reactions. 
6.2.1 Initial designs 
A total of 13 paper prototypes and 15 lamination cut-out prototypes were designed, with 
a total of 27 different 2D µPADs produced. The prototypes can be summarised into two 
main types: the first group (design A) was structured as a central pad connected by 
channels to four side pads (Figure 49).  This design was based on the extensive 
literature available from the early paper-based devices used for detection of glucose and 
protein [9-11], looking at having different analytes tested (up to 4) from one single 
sample. A slight modification to the designs reported in the literature was made to use a 
sample inlet with a wider diameter than the side pads, which allowed for a larger 
quantity of fluid to be deposited without spillage. 
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Figure 49 - Design A of the 2D devices. A) Schematic representation of the design A: central pad for 
sample inlet (r=3mm) (a) and 4 pads (r=2mm) for sample analysis (b) connected by microchannels 
(length=2mm, width=0.5mm). B) Picture taken 2 min after application of 20µl of food colouring in a. 
A second group (design B) was also fabricated, with a central sample pad connected by 
microchannels to an absorbing pad and to a reagent-loading pad (Figure 50). The 
reasoning behind this design was taken from literature regarding lateral flow devices, 
where an absorbing pad is often used [13, 14] to improve the flow rate and to reduce the 
occurrence of non-specific binding between conjugate and substrate, eliminating the 
need for washing steps. 
 
Figure 50 - Design B of the 2D devices. A) Schematic representation of the design B: pads (r=2mm) 
for reagents inlet (a), sample inlet (b) and absorbent pad (c), connected by microchannels 
(length=4.5mm, width=2mm). B) Picture showing the ready-to-use devices. 
6.2.2 Lamination 
The impact of the lamination on the flow rate can also be significant [15] and needs to 
be properly assessed. A set of experiments were performed to test different options for 
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lamination. Two different approaches were investigated: complete covering of the 
microfluidic channels with complete opening of the circular pads or partial covering of 
the whole device (lamination cut-out design smaller than the paper design). Testing of 
these two different methods showed that the first design resulted in a considerably 
slower flow rate (0.08mm/s vs 0.1mm/s) compared to the second design (Figure 51). 
 
Figure 51 - Effect of lamination on the flow rate. On the left, the device has lamination that partially 
covers the paper cut-out. On the right, the device has lamination completely covering the 
microchannels and leaving the paper pads open. Picture taken 2 min after application of 50µl food 
colouring in the reagents inlet.   
6.2.3 Final 2D µPAD 
Based on the final aim of performing a complex biological assay on a µPAD, design B 
was deemed the most appropriate for applying the P-ELISA, mainly due to the need for 
an absorbent pad. Three different prototypes were produced for further testing, based on 
different lamination cut-out: devices 21, 22 and 24 (Figure 52). 
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Figure 52 - The three final prototypes of the 2D µPAD. Black drawings represent the paper cut-out 
(design B) and red drawings the lamination cut-out. Device 21: the lamination is covering the two 
microchannels, leaving the paper pads completely opened (pads lamination r=2mm). Device 22: 
lamination cut-out is partially covering the whole device (pads: r=1.5mm, microchannels: 
length=5.5mm, width=1mm). Device 24: reagents inlet completely open and first microchannel 
completely covered; sample inlet, absorbent pad and second microchannel partially covered. 
6.3 Direct Hp P-ELISA on the 2D µPAD 
A direct Hp P-ELISA was applied to the final 2D µPADs to evaluate the performance of 
the device with an immunoassay. The protocol for the assay was based on the optimised 
haptoglobin (Hp) P-ELISA reported in Section 4.2.2, with specific modification to the 
reagent volumes to suit the 2D design. A total of 10 P-ELISAs were performed, 
showing colorimetric reaction where Hp was deposited on the 2D µPAD (Figure 53).  
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Figure 53 - Direct Hp P-ELISA on device 21. A) Schematic protocol for the P-ELISA on the 2D 
µPAD: 1) 0.7µl of sample (standard bovine Hp at concentration of 64 µg/ml or WB)  were deposited in 
the sample inlet ; 2) after 10 min, 10µl of conjugate antibody diluted 1:750 were deposited in the 
reagents inlet; 3) after 30 min 10µl of substrate solution were deposited in the reagents inlet. B) 
Picture taken 10 min after application of substrate. N: WB, 64: 64µg/ml Hp. The black arrow indicates 
the colorimetric reaction following binding between Hp and conjugate. 
The total time to perform the direct Hp P-ELISA using device 22 was shorter than using 
device 21 (device 21 total assay time: 50 minutes vs device 22 total assay time: 35 
minutes). However, a longer incubation was necessary for the immunological reaction 
to proceed, as demonstrated by the absence of colorimetric reaction when device 22 was 
used (Figure 54). 
 
Figure 54 - Direct Hp P-ELISA on device 22. A) Schematic protocol for the P-ELISA on the 2D 
µPAD: 1) 0.7µl of sample (standard bovine Hp at concentration of 64 µg/ml or WB)  were deposited in 
the sample inlet ; 2) after 10 min, 10µl of conjugate antibody diluted 1:750 were deposited in the 
reagents inlet; 3) after 15 min 10µl of substrate solution were deposited in the reagents inlet. B) 
Picture taken 10 min after application of substrate. N: WB, 64: 64µg/ml Hp. There is no colorimetric 
difference between the device containing Hp and the device with WB. 
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The deposition of reagents within the device could also affect the result of the assay as 
demonstrated by the lack of signal when conjugate and substrate were deposited directly 
onto the sample pad instead of the reagent loading inlet (Figure 55).  
 
Figure 55 - Direct Hp P-ELISA on device 21 with different reagents depositions. A) Schematic 
protocol for the P-ELISA on the 2D µPAD: 1) 0.7µl of sample (standard bovine Hp at concentration of 
64 µg/ml or WB)  were deposited in the sample inlet ; 2) after 10 min, 5µl of conjugate antibody diluted 
1:750 were deposited in the sample inlet; 3) after 10 min 5µl of substrate solution were deposited in the 
sample inlet. B) Picture taken 10 min after application of substrate. N: WB, 64: 64µg/ml Hp. There is 
no colorimetric difference between the device containing Hp (64) and the device with WB (N). 
Furthermore, if the device was not allowed to dry after the conjugate had been deposited 
no colorimetric reaction was detectable in the sample pad (Figure 56). 
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Figure 56 - Direct Hp P-ELISA on device 21 with different timing. A) Schematic protocol for the P-
ELISA on the 2D µPAD: 1) 0.7µl of sample (standard bovine Hp at concentration of 64 µg/ml or WB)  
were deposited in the sample inlet ; 2) after 10 min, 10µl of conjugate antibody diluted 1:750 were 
deposited in the reagents inlet; 3) after 10 min 10µl of substrate solution were deposited in the reagents 
inlet. B) Picture taken 10 min after application of substrate. N: WB, 64: 64µg/ml Hp. There is no 
colorimetric difference between the device containing Hp (64) and the device with WB (N). 
Finally, when device 24 was used, there was a detectable colorimetric reaction where 
Hp had been deposited and the total assay time was 35 minutes (Figure 57). 
 
Figure 57 - Direct Hp P-ELISA on device 24. A) Schematic protocol for the P-ELISA on the 2D 
µPAD: 1) 0.7µl of sample (standard bovine Hp at concentration of 64 µg/ml or WB)  were deposited in 
the sample inlet ; 2) after 10 min, 10µl of conjugate antibody diluted 1:750 were deposited in the 
reagents inlet; 3) after 30 min 10µl of substrate solution were deposited in the reagents inlet. B) 
Picture taken 10 min after application of substrate. N: WB, 32: 32µg/ml Hp. The black arrow indicates 
the colorimetric reaction following binding between Hp and conjugate. 
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6.4 Three-dimensional microfluidic paper-based analytical device (3D µPAD) 
design and fabrication 
The rationale behind developing a 3D µPAD was to eliminate some of the steps 
required by the 2D format (e.g. conjugate addition), aiming at a final device  that would 
only need addition of sample by the operator, as well as the possibility to perform 
multiple tests at one time. 
6.4.1 Initial designs 
A total of 20 prototypes of 3D µPADs were created. The main designs can be 
summarised into design C and design D, both designed to support multiple tests at once. 
The first one, made of two overlapping layers, was based on the concept of adding the 
sample and a wash buffer for rehydration of stored reagents (conjugate and substrate) at 
the same time, with geometries of the microfluidic allowing for difference in timing 
(sample reaching the test pad first, followed by the rehydrated conjugate and finally the 
rehydrated substrate) (Figure 58). 
 
Figure 58 - Design C of the 3D µPAD. A) Exploded view showing the two overlapping layers of the 
device. The black drawing represents the paper cut-out and the red drawing represents the lamination 
cut-out. B) Schematic representation of the assay design: sample inlet, test pad, buffer inlet, conjugate 
storage pad, substrate storage pad and absorbent pads (x2). Paper pads r=3mm, microchannels 
width=1mm and length= 3mm. The black arrows show the fluid flow after the sample is introduced in 
the sample inlet and the buffer in the buffer inlet. 
Design D (Figure 59) was composed of three layers, based on the concept of adding the 
sample and the substrate in sequential order. After the addition of the sample at the 
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device inlet, this would then move towards the stored conjugate and enable its 
rehydration. Incubation occurred while fluid was flowing to the test pad, where the 
immune-complex would be captured by a capture reagent on the test pad. After a period 
of incubation, the substrate would be added at the device inlet. 
 
Figure 59 - Design D of the 3D µPAD. A) Exploded view showing the three overlapping layers of the 
device. The black drawing represents the paper cut-out and the red drawing represents the lamination 
cut-out. B) Schematic representation of the assay design: device inlet (for sequential addition of 
sample and substrate), conjugate storage pad, test pad and absorbent pads. Paper pads r=3mm, 
microchannels width=1mm and length= 3mm. The black arrows show the fluid flow from the device 
inlet to the other parts of the device. 
6.4.2 Assembly of the 3D µPAD 
One of the main challenges encountered when moving from the 2D to the 3D format, 
was the assembly of the device, with precise alignment and minimal space in between 
layers. The technique used for bonding adjacent layers together was based on the use of 
double-sided adhesive tape (3M™ Clear Double Sided Polyester Tape 9088-200 
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thickness, USA). Initially, small squares of tape were attached on the bottom side of the 
laminated layer then the device was assembled. This method, however, showed 
inconsistent results with some of the devices having a physical gap in between layers 
preventing vertical fluid flow (Figure 60). 
 
Figure 60 - Design C of the 3D µPAD with the original assembly technique. Assembly of the device is 
done by using four squares (roughly of 0.5mm2) of double-sided tape at each corner of the laminated 
layer. Picture taken 10 min after application of 20µl food colouring in the sample inlet. The second 
layer  of the device does not enter in direct contact with the first layer  resulting in the absence of 
vertical fluid flow. 
To solve this problem, different solutions were tested. Initially, an overall final 
lamination of the assembled device was considered. This approach had been previously 
reported in literature as a possible solution [16]. Although results were more consistent 
with this technique (Figure 61), thermal lamination could damage the pre-deposited 
reagents resulting in reduced assay performance and would also add a further 
fabrication step to the process. 
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Figure 61 - Design C of the 3D µPAD with overall final lamination. Assembly of the device is done as 
per Figure 60, with an added lamination of the entire device. Picture taken 10 min after application of 
10µl blue food colouring in the sample inlet and 10µl of red food colouring in the buffer inlet. Mixing 
of the two solutions can be seen in the test pad. 
A different approach was therefore explored. The proposed solution, not reported 
before, was to preassemble a lamination and a double-sided adhesive sheet (3M™ 9471 
Laminating Adhesive Rolls, 0.05mm thickness, USA) together (Figure 62A) and then 
apply the laser cutting to the assembly. This resulted in the laminated sheet and the 
double-sided adhesive sheet having the same surface and design (Figure 62B). 
Furthermore, based on the technique developed for the MP3 fabrication, laser cutting of 
pre-designed alignment features allowed for an easier assembly of the final device. The 
new technique resulted in a consistent vertical flow rate within the device and a 
complete wet out of the device without spillage in between layers (Figure 62C). 
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Figure 62 - Design D of the 3D µPAD with the new assembly technique. A) Lamination and double-
sided adhesive sheets are assembled before laser cutting. B) Laminated layer of the device with the 
adhesive sheet matching the lamination design. Each layer of the device is ready for assembly, after 
removal of the adhesive sheet liner (brown coloured). C) Picture of the assembled device 10 min after 
application of 20 µl red food colour in the sample inlet, showing complete fluid flow through each 
layer of the device without spillage . 
6.4.3 Final 3D µPAD 
Based on the knowledge acquired from the experiments performed on the 2D µPAD and 
considering the required steps to perform multiple P-ELISA at the POC, design B was 
deemed as the most suitable solution and prototype 74 was chosen as the final 3D 
µPAD for further testing (Figure 63). The device comprised four layers, each with a 
specific function. Layer A (sample inlet layer) had a wider radius for addition and 
containment of the sample. Layer B (sample distribution layer) delivered the sample to 
two independent areas of the device. Layer C (conjugate storage layer) was for dry 
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reagent storage. Layer D (test layer) contained a single pad for reagents incubation and 
reaction, branching into two microchannels leading to a test pad (where the capture 
reagent is located and the result of the test is displayed) and from there into an absorbent 
pad. After cutting and lamination of each layer, the device was assembled by peeling off 
the liner of layer B, aligning layer C onto layer B and then layer D onto the two 
assembled layers. After removal of the liner from layer A, this was assembled onto the 
partial device to create the full device. The addition of laser cut numbers (74) directed 
the correct alignment of each layer. When 30µl of food colouring were applied, all 
devices tested (n=6) were completely wet out by 5 minutes, with no spillage and fluid 
was also observed to move through layers at the same speed (Figure 63B). 
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Figure 63 - Final 3D µPAD (prototype 74). A) Exploded view of the final 3D µPAD. The black 
drawings represent the paper cut-out and the red drawings the lamination cut-out. a) Layer A: sample 
inlet (paper pad r=8mm, lamination r=6mm). b) Layer B: sample distribution (paper pads r=2mm, 
microchannels length=4.5mm and width=2mm; lamination pads r=1.5mm, microchannels 
length=5.5mm and width=1mm). c) Layer C: conjugate storage (paper pad r=3mm, no lamination). d) 
Layer D: test (paper pads r=2mm, microchannels length=3mm width= 2mm, lamination pads 
r=1.5mm). B) Assembled 3D µPAD (70mm*30mm). To demonstrate mixing of a pre-deposited 
coloured sample, 2µl of red food colouring were deposited in layer C (left side only). After 10 min at 
RT, the device was assembled and 30µl yellow food colouring were added to layer A. Complete wet out 
was reached 5 min after addition of food colouring, and mixing of red and yellow food colouring can 
be seen on the left side of the device. 
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6.5 Direct Hp P-ELISA on the 3D µPAD 
A direct Hp P-ELISA was also applied to the final 3D µPAD, based on the protocol 
used for the 2D device (Figure 53A). The aim was to assess the performance of the 
developed 3D µPAD as a diagnostic platform for immunoassay. The immunoreactions 
were evaluated in relation to the physics of the fluid flow (timing and volumes) as well 
as the location and binding of the reagents within the device. The initial experiments 
showed that complete wet out of the device was achieved, but the conjugate failed to 
reach the test pad, however it did react with the substrate within layer B (Figure 64). 
 
Figure 64 - Experiments on the 3D µPAD with a direct Hp P-ELISA to evaluate conjugate rehydration 
and flowing through the device. A) 2D schematic protocol for the P-ELISA on the 3D µPAD: 0.7µl of 
standard bovine Hp at concentration of 32 µg/ml (g) or 64µg/ml (d) and 0.7 µl WB (e and f) were 
deposited in the sample inlet; 2µl conjugate diluted 1:750 in WB were deposited in the conjugate 
storage pad (b and c); after 10 min at RT, 30µl of WB were added to the sample inlet (a); after 30 min 
at RT, 30µl substrate solution were deposited in the sample inlet (a). B) Picture taken 10 min after 
application of substrate. N: control (WB), 64: 64µg/ml Hp, 32: 32µg/ml Hp. There was no colorimetric 
reaction in any of test pads but there was evidence of reaction between the conjugate and substrate 
within layers A and B. 
To prevent the conjugate from binding to the conjugate storage pad and diffusing into 
layer B, a blocking buffer was used to prevent absorption of reagents onto the device. 
Different blocking buffers were tested, with BSA 10% deemed as the most suitable 
(Figure 65). It was also noticed that a stronger signal could be achieved with a decrease 
in conjugate dilution, without causing an increase in the background signal (Figure 
65C). 
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Figure 65 - Evaluation of conjugate blocking within the  3D µPAD. Layer B and layer C of the device 
were blocked with 2 µl of different solutions of blocking buffer, before a direct Hp P-ELISA was 
carried out as reported in Figure 64. Standard bovine Hp was at concentration of 64µg/ml in both pads 
(d and g), while conjugate was diluted 1:50 in WB for pad b and 1:200 in WB for pad c. A) The 
blocking buffer used is milk 10%. B) The blocking buffer used is fish gelatin 5%. C) The blocking 
buffer used is BSA 10%. The black arrows indicate the colorimetric reaction following binding 
between Hp and conjugate at the test pad. There was a noticeably stronger signal when a conjugate 
concentration of 1:50 was used (pad b). 
Based on the results obtained, the optimised protocol for the direct Hp P-ELISA applied 
to the 3D µPAD was as follows: standard bovine haptoglobin was diluted to 64µg/ml in 
WB and 0.7µL were deposited onto the test pads d and g (Figure 64A) and 0.7µL of 
WB were deposited onto the test pads e and f (Figure 64A). The device was blocked 
with blocking buffer (BSA 10%) as follows: 0.7µL was applied to the first paper pad of 
layer D and 2µL was applied to layers C and B (Figure 63A). After 10 minutes at RT, 
2µL of purified rabbit anti-bovine haptoglobin IgG diluted 1:50 in WB was deposited 
onto layer C and allowed to dry at RT for 10 minutes. The 3D µPAD was assembled 
and 30µl WB was deposited onto layer A. After 30 minutes at RT, 30µl of substrate 
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solution were added to layer A. After 10 minutes at RT, the 3D µPAD was scanned 
using a desktop scanner. A total of 3 replicates of the device were processed (n=6) and 
the image data was analysed as reported in Section 2.5. The mean pixel intensity of the 
positive pad (Hp) was 24.86±4.89 SEM (CI 12.3-37.4) and 6.61±0.67 SEM (CI 4.9-8.3) 
for the control pad (N), showing a significant difference (p=0.019) when a paired t-test 
was used to compare the measurements (Figure 66). 
 
Figure 66 - Optimised direct Hp P-ELISA on the 3D µPAD. A) Picture taken 10 min after addition of 
the substrate. The black arrows indicate the colorimetric reaction following binding between Hp and 
conjugate at the test pad. B) Scatter plot of the mean pixel intensity obtained from 3 replicates (n=6) 
3D µPAD. Hp: pad containing 64µg/ml Hp and N: control pad containing WB. 
6.6 Discussion 
In this final research chapter, the knowledge acquired to fabricate the MP3 and to 
transfer lab-based ELISAs into P-ELISAs are combined with the final aim of 
fabricating a µPAD that could successfully perform an immunoassay at the POC. The 
fabrication method for the paper device, was already demonstrated as a valid alternative 
to the existing methods (Chapter 3) with additional advantages, such as, high resolution 
of fabrication, simplicity, versatility, robustness, low-cost and suitability for high 
environmental temperatures. In relation to fabrication, some fundamental knowledge 
was acquired during the transition from the MP3 into the 2D and 3D format. 
Specifically, an alternative solution to simplify and effectively assemble the device was 
developed. The precise alignment and the removal of gaps between adjacent layers of 
3D µPADs have been reported as some of the main hurdles of these type of platforms 
[17]. Solutions proposed include the use of cellulose powder [18], adhesive spray [19] 
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or lamination of the whole device [20]. The solution proposed herein exploits the same 
machinery (e.g. laser cutter) used for fabrication, by precisely cutting a thin double-
sided adhesive sheet in the same shape as the lamination. This reduces the operator 
input and possibly human error by pre-assembling the adhesive sheet onto the device 
layers. Although the adhesive sheet is then laminated at high temperature (110°C), no 
evidence of leakage or loss of adhesiveness were observed once the device was 
assembled and tested. Furthermore, in the final device, one of the layers (the conjugate 
storage) is not laminated, which allows increased contact between layers and a complete 
usage of the surface available for reagent storage. An important contribution to the 
effect of lamination on timing, was also provided by the experiments performed on the 
2D µPAD. In this case, a partially open device allowed for a faster flow rate, but was 
not compatible with the reaction time necessary for an immunoassay. Although one of 
the fundamental criteria for POC tests is rapidity [21] biological reactions also need a 
minimum time to proceed. Therefore, a combination of different lamination techniques 
has been used to tailor fluid flow according to the timing needed. A partially open layer 
was used to achieve fast sample distribution, while a complete covering of the 
microchannels within the test layer reduced the fluid flow allowing sufficient time for 
the biological reaction to occur. 
In this respect, the µPADs, both the 2D and 3D versions, were also tested with an 
immunoassay, showing that the reaction occurs specifically where the conjugate binds 
to pre-deposited Hp, with minimal background noise (Figure 66). Compared to the P-
ELISA applied on the MP3, a two-step (instead of 5 step) process was required, with 
complete removal of the washing procedures. Experimental work was also initiated for 
the use of the sandwich Hp and the indirect Pso o 2 P-ELISA with serum (results not 
shown). In this case, the capture reagents were deposited in the test layer and serum 
from naïve and infested sheep were added to the sample inlet. This remained a two-step 
process, with further work planned to use a gold-labelled conjugate instead of either an 
ALP or HRP conjugate, with the final aim of reducing the whole assay to a one-step 
process (e.g. addition of sample). The developed 3D µPAD would also allow for the 
sample inlet (layer A) to provide a whole blood separation pad [22], which would 
remove the need for centrifuging whole blood, making the device truly suitable for 
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“pen-side” use. A stage that needs further investigation is the long-term storage of the 
device, with specific reference to the performance of the immunoassay. Experiments 
were carried out on the same day of the conjugate antibody deposition. Further 
experiments would be required to evaluate if similar results can be obtained within days 
or weeks after deposition of the reagents, taking also into account different methods for 
storage of the 3D µPAD (e.g., refrigeration or vacuum packed). 
At this stage, the total time from sample addition to results was 40 minutes. However, a 
waiting time of 30 minutes between the two steps of the assay was based on the 2D 
µPAD experimental work and additional testing on the 3D format could possibly reduce 
it further. Total timing for immunoassays carried out on 3D µPAD vary from 15-30 
minutes [23] to 45 minutes [22], which is generally considered satisfactory. Likewise, 
the total volume of sample used is comparable to other studies using similar devices, 
where between 20µl [24] and 80µl [25] are usually required. 
Finally, the 3D µPAD developed here allows for two immunoassays to be run in 
parallel. However, two further microchannels could be added to the design in layer B, 
leading to the corresponding test layers which could perform a total of four independent 
tests on the same sample. Furthermore, by scaling down the device, a single chip could 
easily support up to four 3D µPADs, allowing for multiple samples to be tested at the 
same time.  
6.7 Conclusions 
To conclude the research, a functional 3D µPAD was developed and fabricated, based 
on the technique of laser cutting and lamination for fabrication and the use of a laser cut 
double-sided adhesive sheet for precise and close-fitting assembly. An immunoassay for 
the detection of Hp was also successfully applied on the device. This demonstrated the 
proof-of-concept that the developed 3D µPAD is suitable as a diagnostic platform for 
immunoassay. To use the device in clinical settings, more complex assays (e.g. 
sandwich ELISA with pre-deposition of a capture antibody) would be required. The 
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device has great potential for application as a “pen-side” test for sheep scab and, to 
widen its application, as a platform for animal disease testing. 
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Chapter 7 – Summary of the research and recommendations for 
further work  
7.1 Summary of the research 
In this thesis, the development of microfluidic paper-based analytical devices (µPADs), 
based on a new fabrication technique and specifically designed to suit point-of-care 
animal disease testing, has been described. Different devices have been developed 
within the research program and their analytical performances have been tested using 
sheep scab as the model disease, in light of future practical applications of these devices 
for point-of-care screening of infested animals (Figure 67). 
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Figure 67 - Summary of the research. A) The novel fabrication technique for production of µPADs. B) 
Schematic of the P-ELISA developed on the MP3 for sheep scab diagnosis. C) Performance of the 
µPADs for POC test of sheep scab: standard curve for Hp measurement (I); correlation between image 
analysis using Image J and the purpose-written MATLAB code (II); correlation between results from 
the lab-based ELISA and the P-ELISA for Pso o 2 measurement at week 6 post-infestation (III). D) 
Final 3D µPAD with the optimised direct Hp P-ELISA. 
The new fabrication technique is based on a combination of paper cutting and 
lamination (Figure 67A). This method is simple, rapid and of high-resolution and can 
produce robust, versatile and low-cost devices. Using this technique, a replicate of a 96-
well microplate for P-ELISA, named MP3, a 2D and a 3D µPAD were fabricated. 
During the development of these devices, alternative assembly methods for both the 
MP3 and the 3D µPAD were engineered, which allowed for easy and precise assemble 
of the devices. Novel fabrication methods, like “draw your assay”, which uses a ball-
point pen to create microfluidic channels [1] or printing of cellulose powder onto a 
polymer film [2], show the need for practical and simple ideas to reduce the costs and 
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simplify the fabrication process. Very recently a new concept of low-cost devices has 
also been introduced, called paper hybrid microfluidic platforms. A combination of 
paper and other materials, like PMMA [3], PDMS [4], cotton [5] or glass [6] are 
combined to fully exploit the properties of each material [7]. The novel fabrication 
technique developed here can be considered an example of this recently characterised 
class of microfluidic platform. 
Another interesting application of microfluidic paper-based devices has been proposed 
to streamline the process of optimising assay conditions [8]. Within the time frame of 
this research project, it was possible to translate two lab-based ELISAs (Hp and Pso o 
2) into P-ELISAs using the MP3 (Figure 67B). The length of time to analyse the data 
was also decreased considerably by developing an alternative solution for automatic 
data analysis (Figure 67C). This is of great relevance for data interpretation at the POC, 
where a rapid answer is an essential characteristic of these type of tests. Furthermore, 
due to the reduced volumes of reagents and the low-cost of consumables, the 
development of the µPADs prototypes and the optimisation of the assays conditions 
were relatively low-cost. 
Important advances in the point-of-care diagnosis of sheep scab have also been 
achieved. P-ELISAs for Hp and Pso o 2 (Figure 67C) were developed and, although 
each step of these assays needs to be manually performed by the operator, overall 
timing and cost were significantly reduced. While it cannot be strictly considered a POC 
test, a P-ELISA on the MP3 can still offer the possibility to carry “in-house” (e.g. within 
veterinary clinics) testing as other ELISA test kits have been commercialised [9] or 
possibly even “on-farm” testing, as is the case for common parasitology techniques for 
faecal egg counts that can currently be performed on farm [10]. Furthermore, the 
application of the 3D µPAD for Hp detection means that the possibility of a “pen-side” 
test for sheep scab is now a real possibility (Figure 67D). 
Finally, but possibly most importantly, the overall success of this PhD project was 
possible due to the strong collaboration between the two institutes and the people 
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involved, engineers and biologists, working closely together in a truly interdisciplinary 
space. 
7.2 Future work 
In view of the results obtained and aiming at a continuation of this research, the 
following areas will need to be addressed in the future: 
• To validate the 3D µPAD with serum from animals with known and varying 
degrees of pathology, in a multiplex format for parallel detection of Hp and Pso 
o 2. Samples are already available and, after optimisation of conditions like 
sample and reagent dilutions, results obtained from the two lab-based ELISAs 
could be compared with results from the multiplexed 3D µPAD. 
• To make the 3D µPAD a true “pen-side” test, by using whole blood instead of 
serum samples. In this case, the sample inlet could act as a blood separation 
membrane, removing the need for a centrifuge. This method has been 
successfully employed before [11, 12], although it has never been applied to 
animal blood, which would provide the first proof-of-concept of this method. 
Implementing it even further, would be the use of a pin-prick derived blood 
sample [13, 14] removing the hurdle of blood collection by jugular veni-
puncture. 
• To further improve the analytical performance of the µPADs. Improvement of 
limit of detection, sensitivity and specificity are still perceived as one of the 
main challenges in microfluidics [15]. The use of an alternative method to 
colorimetric detection, like electrochemical [16, 17] or potentiometric sensors 
[18], could be applied both to the MP3 and the 3D µPAD to enhance detection of 
circulating Hp and Pso o 2 antibodies. 
• To widen the utility of the MP3, by translating other immunoassays into P-
ELISA. Lab-based ELISAs already exist for other important diseases of sheep, 
for example Enzootic Abortion of Ewes (a zoonotic agent causing serious 
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abortion storms) [19] and Maedi-Visna/Caprine Arthritis Encephalitis (an 
important wasting disease of small ruminants) [20]. For both conditions, official 
schemes are in place in the UK for accreditation of flocks as free from the 
disease, which requires annual testing8. These diseases would therefore be well 
suited for a “pen-side” test for regular screening of animals. 
• To obtain POC interpretation of the test results. During this project, a high-
throughput image analysis procedure was developed. The use of desktop 
scanners, however, is only suited for research and laboratory settings. A 
recurrent theme in literature is the use of smart phone cameras for image capture 
[21], which could be used as part of telemedicine approach [22].  Results 
generated by the µPADs could be compared using a desktop scanner and a smart 
phone camera, possibly looking at developing a smart phone app to include the 
algorithm already developed here for image analysis. 
• To look at commercialisation of the µPADs. Last, but not least, the applications 
related to this project should be taken from the laboratory to the end-users. Field 
trials could be designed, looking at involving farmers, vets and diagnostic 
laboratories into trialling the new sheep scab tests, with the possible final aim of 
patenting the µPADs developed [23]. 
7.3 Conclusions 
Research projects on µPADs have seen an exponential increase since the concept was 
first introduced. They represent an excellent solution for low-cost and rapid diagnosis in 
low-resource settings and, as demonstrated through this research, they can also be 
applied to animal disease diagnostics. The application of these new technologies could 
make a real change toward an improved and more sustainable human and animal health. 
However, only true collaboration between engineers, scientists, vets, medics and 
industry partners will enable this to happen. 
                                                 
8 https://www.sruc.ac.uk/info/120113/premium_sheep_and_goat_health_schemes 
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8.1 Lab-based sandwich ELISA for the determination of Haptoglobin 
concentration 
8.1.1 Standard bovine haptoglobin (Hp) 
Standard bovine haptoglobin (0.93mg/ml, Life Diagnostics Inc., USA) was kept at -
80°C and thawed at room temperature before use. 
8.1.2 Antibody conjugation 
Purified rabbit anti-bovine haptoglobin IgG (Life Diagnostics, USA; Catalogue No. 
18120) was conjugated with alkaline phosphatase (Innova biosciences, Cambridge, UK; 
Catalogue No. 702-0010) according to manufacturer’s instruction as described below; 
3.7µl of LL-Modifier was added to lyophilized product in the vial and gently mixed by 
pipetting up and down. 37µl (0.1mg rabbit anti bovine Hp) was then added into the vial, 
mixed and left at room temperature overnight. 3.7µl of LL-Quencher was added the 
next day. The conjugate was ready for use after 30 minutes. 200µl of phosphate 
buffered saline (PBS) was added to the conjugate to give a final volume about 244.4µl, 
and an antibody concentration of 0.4mg/ml. This was stored at 4oC until used. 
8.1.3 Coating 
Unconjugated purified rabbit anti-bovine haptoglobin IgG (Life Diagnostics, USA; 
Catalogue No. 18120) was diluted to a final concentration of 0.125µg/ml in coating 
buffer (0.05M NaHCO3 pH 9.6). 100µl was dispensed into individual wells of Nunc-
Maxisorp 96 MicroWell™ plate (Nunc International, Rochester, NY) and incubated at 
4oC overnight. 
8.1.4 Washing 
After discarding the antibody solution, each well was washed with 250µl of wash buffer 
[(WB) 0.02M Tris-HCl with 0.05% Tween-20 (pH 7.4)], four times. 
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8.1.5 Blocking  
Unoccupied binding sites were blocked by adding 200μl of blocking buffer, 10% (w/v) 
Marvel milk protein in WB, and incubated at 37oC for 60 minutes. 
8.1.6  Addition of standards and samples  
After washing, standard bovine haptoglobin (Hp) was diluted to 1025ng/ml in WB and 
then double diluted until it reached 8ng/ml. Milk samples were also diluted at 1:800 or 
1:1000 in WB. Serum samples were diluted 1:40 in WB. 100μl of each Hp, milk and 
serum samples were added into duplicate wells and incubated at 37 °C for 60 minutes. 
8.1.7 Addition of conjugate antibody 
Wells were washed, and 100µl of the alkaline phosphatase-conjugated antibody diluted 
at 1:10,000 in WB were dispensed into each well of the ELISA plate and incubated at 
room temperature (RT) for 60 minutes. 
8.1.8 Addition of substrate  
After washing, substrate solution, BluePhos® Microwell phosphatase substrate system 
by KPL (Catalogue No 50-88-00) was made up according to manufacturer’s instruction 
and 100µl was added into each well for colour development taking approximately 10 
minutes. APstopTM solution (KPL Catalogue No 50-89-00) was used by adding 100µl 
per well, to stop further colour development after the optimum was reached. 
8.1.9 Absorbance reading 
The absorbance was read at 595nm using Fluostar OPTIMA plate reader (BMG Labtech 
Ltd.) and the results analysed and calculated using the associated FLUOstar OPTIMA 
Software V1.32 R2 using a 4 parameter-fit standard curve plotted on a Log-linear scale. 
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8.1.10 Assay validation 
Precision of the assay was determined by calculating the means of inter- and intra-assay 
coefficients of variation (CV) of 11 inter-assay repeats of two controls and 23 samples 
in one run assay, respectively. Limit of detection (sensitivity) of the assay was 
determined from 4 blanks samples plus 3 standard deviations. The specificity of the 
assay was assessed by western immunoblots, nitrocellulose membrane incubation in 
conjugate Ab, followed by detection using enzyme substrate, of Hp containing milk and 
serum samples and samples spiked with known concentrations of standard bovine Hp. 
Recovery was assessed by determining Hp concentration of the spiked samples using 
the ELISA assay. 
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9.1 Lab-based indirect ELISA for the detection of ovine IgG binding to 
recombinant Pso o 2 
9.1.1 Recombinant Psorptes ovis Pso o2 (rPso o 2) 
The rPso o 2 (0.51mg/ml, Dundee Cell, UK) was kept at 4°C. It was brought to room 
temperature (RT) and thoroughly mixed by vortexing before use. 
9.1.2 Coating 
The rPso o 2 was diluted in double distilled water to a concentration of 2.5µg/ml. 50µl 
were dispensed into individual wells of flat bottomed, medium binding 96-well plates 
(Greiner code 655001) and incubated at RT overnight. 
9.1.3 Washing 
After discarding the antigen solution, each well was washed with 300µl of wash buffer 
[(WB) phosphate buffered saline (PBS) with 0.05% Tween-20], six times. 
9.1.4 Blocking  
Unoccupied binding sites were blocked by adding 100μl of blocking buffer [(PBST80) 
0.5M NaCl PBS with 0.05% Tween 80] and incubated at 37oC for 60 minutes. 
9.1.5  Addition of animal samples  
After washing, 50µl of ovine serum samples diluted 1:400 in PBST80 were added into 
duplicate wells and incubated at 37 °C for 60 minutes. 
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9.1.6 Addition of conjugate antibody 
Wells were washed, and 50µl of rabbit anti-ovine IgG horse radish peroxidase conjugate 
(DAKO P0163) diluted at 1: 2,000 in PBST80 were dispensed into each well and 
incubated at 37 °C for 60 minutes. 
9.1.7 Addition of substrate  
After washing, 50 µl of substrate solution [3,3’,5,5’-Tetramethylbenzidine TMB (KPL 
Catalogue No 52-00-00)] was added into each well for colour development taking 
approximately 10 minutes. TMB stopping solution [(100% diethylene glycol (KPL 
Catalogue No 50-85-06)] was used by adding 50µl per well, to stop further colour 
development after the optimum was reached. 
9.1.8 Absorbance reading 
The absorbance was read at 450nm using the Sunrise™ TECAN plate reader (Tecan 
Trading AG, Switzerland) and the results analysed using the associated Magellan™ 
software V6. 
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10.1 MATLAB code for high-throughput analysis of data on the MP3 
function [Wt] = Valentina2(RGB_I, c_dia, mode) 
% function [Wt] = Valentina(RGB_I, mode) 
% Image analysis algorithm to automatically analyse the mean intensity 
of  
% each well in the microfluidic device 
% 
%   Inputs:  RGB_I    = input image 
%            c_dia    = circle diameter for well region-of-interest 
%            mode     = intensity mode 
%                         - 'blue'  = Extract blue channel as 
grayscale 
%                         - 'red'   = Extract red channel as grayscale 
%                         - 'green' = Extract green channel as 
grayscale 
%                         - 'gray'  = Standard grayscale conversion 
%   Outputs: Wt       = Coordinates and mean intensity of each well 
% 
% Version 2.21 
% Algorithm created by Alan Faulkner-Jones  January 2016 
  
close all 
% ----------------------- User Defined Variables ---------------------
---- 
if(~exist('RGB_I','var')) 
%     RGB_I = imread('005.jpg'); 
    [filename,pathname] = uigetfile('*.*','Select the image file'); 
    imagefile = fullfile(pathname,filename); 
    if isequal(imagefile,0) % Catch "Cancel" 
        return 
    else 
        RGB_I = imread(imagefile); 
    end 
end 
if(~exist('c_dia','var')) 
    c_dia = 15; 
end 
if(~exist('mode','var')) 
%     mode = 'gray'; 
    mode = 'blue'; 
end 
  
% ---------------------------- Transform image -----------------------
---- 
% Reduce the size of the image to speed up execution 
I = imresize(RGB_I,0.15);  
  
% Using user-specified mode transform to grayscale 
switch mode 
    case 'blue' 
        I2 = I(:,:,1); 
    case 'red' 
        I2 = I(:,:,2); 
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    case 'green' 
        I2 = I(:,:,3); 
    otherwise 
        I2 = rgb2gray(I); 
end 
  
% Invert the image 
I2 = imcomplement(I2); 
  
% Calculate deviation from orthogonal and straighten the image 
angle = horizon(I2, 0.1, 'hough'); 
I2 = imrotate(I2,-angle,'bilinear','crop'); 
  
% Ask the user to position two ellipses on the opposing corner wells 
to 
% calculate the coordinates of the entire array 
figure(1), imshow(I2); 
title('Move the circles to A1, H12 and double-click each one');  
set(gcf, 'Position', get(0,'Screensize')); % Maximize figure. 
hold on 
h1 = imellipse(gca, [20 20 30 30]); 
h2 = imellipse(gca, [size(I2,2)-30 size(I2,1)-30 30 30]); 
position1 = wait(h1); 
position2 = wait(h2); 
hold off 
  
  
scsz = get(0,'Screensize'); 
% h=msgbox('Please Wait','Computing'); 
h = dialog('Position',[(scsz(3)/2)-125 (scsz(4)/2)-50 250 100],... 
    'Name', 'Message'); 
txt = uicontrol('Parent',h,... 
    'Style','text',... 
    'Position',[20 20 210 40],... 
    'String','Computing, please wait.'); 
  
% ----------- Calculate array coordinates and measure intensity ------
---- 
% Calculate well spacings 
x_spc = (mean(position2(:,1)) - mean(position1(:,1))) / 11; 
y_spc = (mean(position2(:,2)) - mean(position1(:,2))) / 7; 
  
Wt = zeros(96,3);           % Create empty array to store data 
  
figure(1), imshow(I2); 
title('Calculated mean intensity in each well');  
hold on 
n = 1; 
for i = mean(position1(:,1)):x_spc:mean(position2(:,1)) 
    for j = mean(position1(:,2)):y_spc:mean(position2(:,2)) 
        plot(i,j, 'r+')                     % Plot well centres 
        [a,b] = circle(i,j,c_dia); 
        plot(a,b, '-b')                     % Plot circles 
        avg_i = mean(I2(roipoly(I2,a,b)));  % Calculate mean intensity 
        text(i+c_dia,j+c_dia,int2str(avg_i),'Color','r')% Display 
intensity valve 
        Wt(n,:) = [i,j,avg_i];              % Save to array 
        n = n+1; 
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    end 
end 
  
delete(h) 
  
% Reshape the array to 12x8 for ease of cell identification 
WtR = reshape(Wt(:,3),[8,12]);   
  
% ------------------------- Output File Setup ------------------------
---- 
% Create excel spreadsheet with same names as input file 
token = strcat(strtok(filename, '.'),'.xlsx'); 
% [filename2, pathname2] = uiputfile; 
[filename2, pathname2] = uiputfile( ... 
    {'*.xlsx', 'Excel Workbook'}, ... 
    'Save Excel Data File As', ... 
    token); 
if isequal([filename2,pathname2],[0,0]) % Catch "Cancel" 
    return 
else 
    % If we have reached this point, then we need to create the file 
    File2 = fullfile(pathname2,filename2); % Create new file 
    xlswrite(File2,{filename},1,'A1') 
    % Create and insert row and column headers 
    Col_h = {'1','2','3','4','5','6','7','8','9','10','11','12'}; 
    Row_h = {'A';'B';'C';'D';'E';'F';'G';'H'}; 
    xlswrite(File2,Col_h,1,'B3') 
    xlswrite(File2,Row_h,1,'A4') 
    % Write intensity data 
    xlswrite(File2,WtR,1,'B4') 
end 
h = msgbox('Operation Completed','Done'); 
end 
  
function [a,b] = circle(x,y,r) 
%x and y are the coordinates of the center of the circle 
%r is the radius of the circle 
%0.01 is the angle step, bigger values will draw the circle faster but 
%you might notice imperfections (not very smooth) 
ang=0:0.01:2*pi;  
xp=r*cos(ang); 
yp=r*sin(ang); 
a = x+xp; 
b = y+yp; 
end 
